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ABSTRACT 
Vascular permeability and angiogenesis are crucial events in the rodent and human uterus 
in early pregnancy and are regulated by vascular endothelial growth factor (VEGF) and 
prostaglandins liberated from arachidonic acid by cyclooxygenase 2 (COX2). These 
events coincide with the typical morphological features of the receptive uterus and are 
regulated by synchronized release of ovarian hormones (oestrogen and progesterone). 
However, administration of follicle stimulating hormone (FSH) and human chorionic 
gonadotropin (hCG), commonly used in assisted reproduction, affect the synchrony of the 
hormonal milieu, particularly by increasing oestrogen levels. This causes detrimental 
changes to the uterine morphology and affects vascular permeability at the site of 
implantation. In the present study, the expression of COX2 and VEGF was compared 
between control and hyperstimulated rat uteri during the peri-implantation period using 
immunohistochemistry and Western blot analysis. 
While in control pregnant rats COX2 and VEGF immunolocalization occurred in the 
luminal epithelial cells and stroma on consecutive days, strong immunolocalization of 
COX2 and VEGF occurred in the luminal epithelial cells but was inhibited in the stroma 
of the hyperstimulated rats. This appears to have resulted in the suppression of stromal 
decidualization and vascular permeability. Western blot analysis did not show any 
results. This may be due to low concentrations of the protein in the sample. Since 
vascular permeability and angiogenesis are critical to the process of implantation and are 
influenced by VEGF and COX2, disturbance of the pattern of these two proteins by 
hyperstimulation may contribute to the low implantation rate in IVF programes. 
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1.0 INTRODUCTION 
Approximately 35 to 70 million couples worldwide face the problem of infertility 
(Schultz and Williams, 2002).  Infertility is defined as an inability to conceive an 
intrauterine pregnancy after a year of sexual intercourse without contraception.  A 
number of causes in both partners can lead to infertility. Some of these are ovulatory 
problems, fallopian tube blockage, endometriosis, decreased sperm count or motility, or 
abnormal sperm morphology.  The majority of these causes can be successfully treated, 
but some remain unexplained (Tabibzadeh, 1998).   
 
In 1978 the first “test tube baby” was born as a result of the in vitro fertilisation (IVF) 
and embryo transfer (ET) technique (Edwards et al., 1980).  It thus seemed that it was 
possible to resolve the infertility problem.  While ongoing research helped to understand 
the complex process of fertilization, blastocyst stages, differentiation of the uterus to the 
receptive stage and attachment and implantation of the blastocyst, the use of the IVF and 
ET techniques did not increase implantation rates markedly, despite the improvement in 
selection and transfer of healthy embryos (Psychoyos & Martel, 1985; Sterzik et al., 
1988; Duc-Goiran et al., 1999; Ma et al., 2003). 
 
1.1 Controlled ovarian stimulation 
Discovery of the endocrine hypophyseal-gonadal axis early in the 20th century and 
purification of two separate gonadotropic hormones, FSH and LH, opened an era of 
ovarian stimulation (Macklon et al., 2006).  Over the last 25 years of controlled ovarian 
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stimulation (COS)/hyperstimulation used in IVF and ET techniques, various protocols 
were introduced in order to induce growth of multiple antral follicles (superovulation) 
and thus obtain many oocytes for IVF and ET (Macklon et al., 2006).  Increased numbers 
of oocytes are required in order to ensure transfer of sufficient numbers of blastocysts to 
the mother in order to ensure implantation of at least one blastocyst.  
 
One of the commonly used superovulatory drugs is clomiphene citrate (CC).  CC has few 
long term side effects and is simple to use (Edwards et al., 1996; Macklon et al., 2006).  
Despite successful superovulation in CC-treated patients, implantation rates are very low 
(Macklon et al., 2006).  It has been shown that CC affects normal uterine histology and 
ultrastructure, which in turn affects uterine receptivity (Hosie and Murphy, 1992; Hosie 
and Murphy, 1995).   
 
Pregnancy rates in patients treated with CC alone are lower, compared with pregnancy 
rates in patients treated with gonadotropins (Macklon et al., 2006).  Gonadotropins are 
thus still widely and most commonly used in IVF and ET techniques (Edwards et al., 
1996; Macklon et al., 2006).  Successful implantation rates depend on the type of ovarian 
stimulation used (Sterzik et al., 1988) where doses of gonadotropins used are adjusted 
according to individual ovarian response (Macklon et al., 2006).  Even so, use of 
exogenous hormones in these techniques is implicated in the low implantation rates.  In 
addition, the low percentage of successful pregnancies after IVF and ET, commonly 
result in multiple pregnancies. This creates another set of problems, often causing 
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maternal and neonatal complications, as well as increased cost in delivery and neonatal 
care (Edwards et al., 1996; Krussel et al., 2003). 
1.2 Effect of hyperstimulation on the uterus   
As medico-legal and ethical problems restrict researchers from carrying out research on 
the human uterus, a rodent model is most often used for experimental studies.  The 
previous studies in rodents showed that the use of exogenous hormones, superimposed on 
the normal hormonal milieu, induces a rise in oestrogen and progesterone levels and 
affects the progesterone:oestradiol ratio (Gidley-Baird et. al., 1986; Kramer et al., 1990) 
during the peri-implantation period.  Since an increase in oestrogen levels alters gross 
morphological and histological appearance of the uterus (Gidley-Baird et al., 1986; 
Kramer et al., 1990; Stein et al., 1993; Simon et al., 1995.), as well as the expression of 
implantation related genes (Ma et al., 2003), events in normal pregnancy need to be 
understood in order to explain changes that may occur during application of IVF 
techniques. 
  
In mammals, implantation is a dynamic process where the blastocyst comes into close 
physical and physiological contact with the receptive uterus (Enders and Schlafke, 1967; 
Tranguch et al., 2005).  Successful attachment and implantation of the blastocyst is 
governed by synchrony between the receptive uterus and the blastocyst and is related to 
exquisite hormonal control.  During the oestrous cycle in mammals, the uterus is in the 
refractory stage for most of the time (Psychoyos, 1973).  Under the influence of the 
steroid hormones, oestrogen and progesterone, the uterus undergoes a series of changes 
that lead to its receptivity.  The receptive stage, also known as the ”window” of 
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implantation, is a limited period of time during which the uterus supports blastocyst 
attachment and implantation (Psychoyos, 1973; Paria et al., 1993; Ma et al., 2003).  It has 
also been shown that the duration of the “window” of uterine receptivity is dependent on 
oestrogen levels in mice (Ma et al., 2003).  Lower oestrogen levels maintain the 
“window” of implantation open for a longer period of time, while it closes rapidly at 
higher levels (Ma et al., 2003).  In mice, the uterus becomes receptive on day 4 of 
pregnancy and proceeds to a refractory state on day 5, which lasts for about 18h 
(Psychoyos, 1973), while in the rat, the uterus becomes receptive on day 5 and becomes 
non-receptive to blastocyst implantation by day 6 (Paria et al., 1993).  In humans the 
uterus is receptive between days 19-24 of the menstrual cycle. While oestrogen appears 
to influence the duration of uterine receptivity, the ratio between progesterone and 
oestrogen plays an important role in providing the normal morphology for implantation 
during this period.   
  
At the onset of the receptive stage, the blastocysts are in close contact (apposition) with 
the luminal epithelium (Chen et al., 2000).  In rodents, the blastocyst is positioned at the 
antimesometrial side of the uterus with the embryonic pole of the blastocyst facing the 
mesometrial side (Enders and Schlafke, 1967).  On day 5 of pregnancy in the rat, it is still 
possible to flush the blastocysts from the uterus.  The pontamine blue reaction, which is 
predicated on vascular permeability, is usually not demonstrable at this stage (Enders and 
Schlafke, 1967). 
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In order for the blastocyst to implant, the endometrium must be in a receptive state to 
receive it.  The receptive state is characterised by particular morphological features. 
However, the superphysiological oestrogen and progesterone levels recorded in 
hyperstimulated animals and humans, cause detrimental changes to the uterine 
morphology and affect uterine receptivity (Gidley-Baird et. al., 1986; Testart 1987; 
Kramer et al., 1990; Stein et. al., 1993; Simon et. al., 1995). 
   
The attachment reaction occurs between the plasma membrane of the uterine epithelial 
cells and the trophoblast of the blastocyst (Murphy, 1992) under synchronized interaction 
of oestrogen and progesterone (Ljungkvist, 1972).  In the normal pregnant rat uterus on 
day 5 of pregnancy, luminal epithelial cells are simple columnar and their apical borders 
are covered with numerous short microvilli (Enders and Schlafke, 1967).  These cells 
contain large and numerous lipid droplets which are basally situated.  The presence of 
lipid droplets in the luminal epithelial cells displaces the nucleus from the base of the cell 
to a central position (Enders and Schlafke, 1967).  These features of the receptive 
epithelium are altered with raised oestrogen levels in hyperstimulated animals.  In rats 
hyperstimulated with FSH and hCG, the luminal epithelial cells are tall columnar and 
covered with long microvilli (Kramer et al., 1990).  Lipid droplets are absent in these 
cells and the nucleus is basally situated.  Treatment with oestradiol only causes 
hypertrophy and hyperplasia of the luminal epithelium, appearance of long apical 
microvilli and the reduction of lipid droplets within these cells in the rat uterus 
(Ljunkvist, 1972; Williams and Rogers, 1980). 
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Observations in the pseudopregnant rat showed replacement of microvilli with irregular 
projections of the cytoplasm eighteen hours after oestrogen treatment (Ljunkvist, 1972).  
These large apical cytoplasmic protrusions, physically overlying the rest of the uterine 
surface are also known as pinopodes (Psychoyos, 1973; Psychoyos and Martel, 1985; 
Klentzeris 1997; Carson et al., 2000) or uterodomes in the human uterus (Adams et al., 
2004), and are progesterone dependent, while, oestrogen inhibits their expression (Martel 
et al., 1991).  The function of pinopodes is not fully understood.  However, it appears that 
pinopodes are involved in the reduction of the intraluminal fluid, allowing the blastocyst 
to come into close contact with the uterine epithelium (Psychoyos and Martel 1985).  
Bagot et al. (2001) stated that the pinopodes are probably a more sensitive marker of the 
window of implantation than any other histological feature of the luminal epithelial cells 
or detection of any molecular marker currently available.  Pinopodes are observed on the 
surface epithelium of the human endometrium on days 19-21 of the menstrual cycle 
(Nikas et al., 1995) and in mice at day 5 of pregnancy (Psychoyos, 1973).  However, in 
controlled ovarian hyperstimulation cycles, uterodomes are present on days 19-20, 
suggesting premature uterine receptivity (Adams et al., 2004).  
 
Apposition of the blastocyst to the luminal epithelium of the uterus is followed by the 
attachment reaction. Carbohydrates, integrins and other cell-surface molecules contribute 
to the adhesion of the blastocyst at the implantation site (Murphy, 1995; Paria et al., 
2002).  During the peri-implantation period in normal pregnant rats, uterine luminal 
epithelial cells demonstrate an increase in at least four different carbohydrate molecules 
(Murphy and Turner, 1991).  One of these carbohydrates, the trisaccharides of 
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glucosamine are absent on day one of pregnancy, but increase significantly at the time of 
implantation (Murphy and Turner, 1991).  Production of glucosamine trisaccharides in 
the glycocalyx of surface epithelial endometrial cells is inhibited in hyperstimulated 
pregnant rats affecting receptivity of the endometrium for blastocyst implantation 
(Kramer et al., 1994; Peverini and Kramer, 1995).  In addition, studies in hyperstimulated 
rodents showed that the number of implanted embryos was highly affected.  Although 
embryos were present in the dilated lumina of the uterine horns at 5.5 and 6.5 days of 
hyperstimulated rats, it appeared that aberrant distribution of the adhesion molecules 
suppressed their attachment to the luminal epithelium and embryos were found lying 
freely in the lumen of the uterus (Kramer, 1997). 
 
After the attachment reaction, the luminal epithelial cells of the uterus undergo apoptosis 
(programmed cell death), which facilitates the invasion of the maternal endometrium by 
the blastocyst (Parr et al., 1987; Tsujii and Du Bois, 1995; Carson et al., 2000; Tassell et 
al., 2000; Zhang and Paria, 2006).  At the same time, extensive proliferation and 
differentiation of the stromal cells form decidua (Enders and Schlafke, 1967; Kramer et 
al., 1990; Kramer, 1997; Carson et al., 2000).  Under the influence of exogenous 
hormones, decidualisation is affected in rats and results in the stromal cells remaining flat 
and fibroblastic (Kramer et al., 1990; Kramer, 1997).     
 
1.3 Effect of exogenous hormones on embryo quality  
In addition to endometrial receptivity, embryo quality is also important for successful 
implantation.  It has been suggested that hyperstimulation causes a decreased 
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developmental ability of the embryos as a result of an increased proportion of 
chromosomal abnormalities in these embryos (Ertzeid and Storeng, 2001).  Embryo 
donation studies in mice showed significantly lower implantation rates when the embryos 
from superovulated donors were transferred into control recipients, compared to that of 
control donors (Ertzeid and Storeng, 2001).  It has also been reported that 
hyperstimulation of mice causes a delay in the development of embryos in vitro (Ertzeid 
and Storeng, 2001).  Similarly in the human uterus, use of exogenous hormones causes a 
rise in oestradiol levels and affects embryo quality (Valbuena et al., 2001).  Existing data 
concerning research on human embryos, suggest that high oestrogen levels have a toxic 
effect on the cleavage stage of embryos, as well as affecting their adhesion in vitro 
(Valbuena et al., 2001). 
 
1.4 The expression of implantation-related genes 
Many molecules and genes are important for implantation.  However, the sequence of 
gene expression of these molecules during the period of implantation and their interaction 
and relationship is still not well understood (Paria et al., 2002).  To date, the best 
understood signalling sequence in implantation of mice embryos has been established 
with the target deletion of Hoxa-10, leukaemia inhibitory factor (LIF) and 
cyclooxygenase2 (COX2) (Paria et al., 2002).   
 
Due to epithelial-mesenchymal interactions between the uterus and the embryo during 
implantation, many classes of developmental genes are involved in the molecular cross-
talk at the time of implantation (Paria et al., 2002).  Some of these genes are those 
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encoding for fibroblast growth factor, bone morphogenetic proteins, Indian hedgehog as 
well as the Homeobox of transcription factors.  Homeobox (Hox) genes are vital during 
embryogenesis of the genitourinary tract, and particularly Hox10 gene expression is 
required for endometrial receptivity and embryo implantation (Taylor et al., 1997; Bagot 
et al., 2001).  It has been previously reported that mice with a Hox10 gene disruption 
produce viable embryos, but these embryos fail to implant into the Hox 10-deficient 
mouse uterus (Satokata et al., 1995).  However, if the embryos of Hox10-deficient mice 
are transferred into the uterus of wild-type mice, implantation occurs (Satokata et al., 
1995).  Studies of the mouse and human uterus confirmed that maternal Hox10 
expression is required for uterine receptivity (Satokata et al., 1995; Taylor et al., 1997). 
     
In the cytokine family, one of the essential cytokines for preparation of the uterus for 
implantation is leukaemia inhibitory factor (LIF).  In mice, LIF is expressed in the uterine 
glands on day 4 of pregnancy in response to nidatory oestrogen, indicating its 
involvement in the preparation of the uterus for implantation (Song et al., 2000).  LIF is 
also expressed in the stromal cells at the site of blastocyst implantation during the 
attachment reaction on day 5 of pregnancy (Song et al., 2000).  Mutation of the LIF gene 
in mice results in failure of implantation (Sharkey, 1998; Song et al., 2000; Dey et al., 
2004).  Mice with the target disruption of the LIF gene show aberrant expression of some 
of the EGF family of growth factors at the time of implantation, suggesting the 
importance of synergistic expression of these factors (Song et al., 2000).  While LIF is 
particularly important for the attachment reaction, another member of the cytokine 
family, interleukin-11 (IL-11) is primarily involved in decidualization (Paria et al., 2002).  
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Numerous growth factors are also important signalling molecules at the site of 
implantation.  The epidermal growth factor (EGF) family of growth factors includes EGF 
itself, transforming growth factor- (TGF- ), heparin binding-EGF (HB-EGF), 
amphiregulin (Ar), -cellulin (BTC) epiregulin (Er), heregulins/neu-differentiating 
factors (NDFs)and cripto (Carson et al., 2000).  These factors are expressed in a 
spaciotemporal manner suggesting their involvement as local mediators at the time of 
implantation. TGF-  is expressed in the mouse uterus at the time of implantation.  
However, TGF-  mutant mice are fertile, suggesting that the deficiency might be 
compensated for by other growth factors (Carson et al., 2000).  Heparin binding EGF-like 
growth factor is the earliest known marker of implantation in mice (Paria et al., 2002).  
The expression of HB-EGF is evident in the luminal epithelial cells surrounding the 
blastocyst, suggesting that the signals from the blastocyst initiate expression of HB-EGF.  
In addition, experiments in vitro showed that HB-EGF stimulates blastocyst proliferation, 
zona hatching, trophoblast outgrowth and phosphorylation of the receptor in the mouse 
blastocyst (Carson et al., 2000).  Soluble HB-EGF is used to improve the development of 
in vitro-fertilized human embryos (Martin et al., 1998) 
 
1.5 Vascular permeability and angiogenesis 
Two major events which occur at the site of implantation are vascular permeability and 
angiogenesis. Vascular permeability and stromal oedema in the uterus of rodents are 
apparent during the attachment reaction and can be demonstrated by an intravenous 
injection of a macromolecular blue dye, pontamine blue, resulting in the formation of 
blue segmental bands along the length of the uterine horns (Psychoyos, 1973).  Vascular 
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permeability at the site of implantation occurs as a result of the fenestrations of 
endometrial thin-walled vessels (Kramer et al., 1993).  
Vascular permeability occurs as a response to the angiogenic stimuli (Hyder and Stancel, 
1999) in order to allow fibrinogen and other plasma proteins to infiltrate the surrounding 
tissue (Dvorak et al., 1995).  This results in the formation of extracellular fibrin gel which 
is a suitable substrate for endothelial and tumour cell growth (Dvorak et al., 1995). 
  
Cyclical changes in the ovaries and uterus during the menstrual cycle and the process of 
placentation during pregnancy require increased blood flow, which is maintained by the 
formation of new blood vessels.  Angiogenesis is a complex process where new blood 
vessels arise from the pre-existing vasculature (Perrot-Applanat et al., 2000; Robinson 
and Stringer, 2001).  Angiogenesis is achieved by proliferation, migration and tissue 
infiltration of capillary endothelial cells and localised breakdown of the extracellular 
matrix (Hyder and Stancel, 1999).  As a result of these events, new capillaries are formed 
(Dvorak et al., 1995; Hyder and Stancel, 1999; Robinson and Stringer, 2001).  During 
angiogenesis new capillaries originate from the smaller blood vessels, capillaries and 
venules (Hyder and Stancel, 1999).  New blood vessels also develop by the process of 
vasculogenesis, from hemangioblasts (Coffin and Poole, 1988). 
 
Angiogenesis is important in embryogenesis and tissue development.  In adults, 
angiogenesis occurs primarily in the female reproductive tract, at the site of wound 
healing and bone remodelling (Robinson and Stringer, 2001).  Apart from the normal 
physiological conditions in adults, angiogenesis is implicated in several pathological 
 12 
conditions, such as diabetic retinopathy, rheumatoid arthritis and development of tumours 
(Folkman, 1990; Ferrara, 1996; Kim et al., 1996). 
Vascular permeability and angiogenesis in the female reproductive tract are regulated in 
different ways by oestrogen and progesterone in vivo (Matsumoto et al., 2002).  
Oestrogen induces uterine vascular permeability and inhibits angiogenesis, while 
progesterone stimulates angiogenesis and does not affect vascular permeability 
(Matsumoto et al., 2002).  Numerous vasoactive agents such as histamine, platelet-
activating factor, prostaglandins, fibroblast growth factor (FGF) and vascular endothelial 
growth factor (VEGF) are important for vascular permeability at the site of implantation 
(Hyder & Stancel, 1999; Paria et al., 2002).  
 
1.5.1 Vascular endothelial growth factor (VEGF)  
The first discovery of a permeability factor secreted by hepatocarcinoma cell lines that 
induced dye leakage into the skin of the guinea pig was described by Senger et al. (1983).  
This permeability factor was later cloned and named vascular endothelial growth factor 
(VEGF) for its mitogenic effect on endothelium in culture (Leung et al., 1989).  VEGF is 
a glycoprotein, which exists in multiple isoforms that work primarily via two 
transmembrane tyrosine kinase receptors: VEGFR-1 encoded by Flt-1, and VEGFR-2 
encoded by KDR Flk-1 (Matsumoto et al., 2002).  Both receptors are exclusively 
expressed on endothelial cells. It appears that VEGF does not increase mitogenesis in any 
other cell type (Leung et al., 1983; Roberts and Palade, 1995; Ferrara, 1996).  The role of 
VEGF as a potent permeability factor has been studied by Roberts and Palade (1995).  It 
has been shown that application of VEGF induces fenestrations of small venules and 
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capillaries in the cremaster muscle, which does not normally have a fenestrated 
endothelium in its vascular bed (Roberts and Palade, 1995). 
VEGF-A is a member of a larger VEGF family that includes VEGF-B, VEGF-C, VEGF-
D, VEGF-E and placental growth factor (PlGF) (Bates and Harper, 2003).  VEGF-B is 
mainly distributed in heart and skeletal muscle, PlGF in the placenta, while VEGF-C and 
VEGF-D are related to lymphogenesis and maintenance of lymphatic vessels (Robinson 
and Stringer, 2001).  
   
VEGF-A exists in several isoforms (Fig. 1), derived from the single gene through 
alternative gene mRNA spicing (Robinson and Stringer, 2001; Krussel et al., 2003). 
VEGF protein in humans consists of 121, 145, 165, 189 and 206 amino acids (VEGF 121, 
VEGF 145, VEGF 165, VEGF 189, and VEGF 206).   
 
 
 
Fig. 1:   Five different VEGF isoforms (Krussel et al., 2003) 
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In rodents, different isoforms of VEGF protein contain one amino acid less than in 
humans.  VEGF 121 and VEGF 165 are predominant isoforms in humans, while VEGF 120 
and VEGF 164 are more predominant in mice (Ma et al., 2001).  All VEGF isoforms 
contain 8 exons of which 1-5 and exon 8 are constituents for all isoforms (Fig. 1) 
(Krussel et al., 2003).  Different isoforms are dependant on various combinations in 
additions of exons 6 and 7 (Bates and Harper, 2003).  VEGF isoforms exist in secreted 
forms (VEGF 121, 145, 165) or they are bound to the cell surface (VEGF 189, 206) (Houck et 
al., 1991; Bates and Harper, 2003).  All secreted VEGF isoforms bind to 
transmembranous tyrosine kinase receptors Flt-1 and KDR (Fig. 2).   
 
                                              
Fig. 2:   Schematic illustration of VEGF receptors and their interaction with 
different growth factors (Krussel et al., 2003) 
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Although VEGF has a greater affinity for binding to Flt-1 than KDR, it appears that its 
biological response is facilitated through the binding of VEGF to KDR rather than Flt-1 
(Waltenberger et al., 1994).  However, both receptors and their interactions are required 
in order to induce VEGF biological responses (Ferrara, 1996; Ferrara and Davis-Smith, 
1997).  VEGF binding to these receptors causes phosphorylation and signal transduction 
that causes vascular permeability and angiogenesis (Krussel et al., 2003; Bates and 
Harper, 2003).   Waltenberger et al. (1994) reported that KDR mediates chemotaxis, 
mitogenesis and cytoskeletal reorganization of endothelial cells. 
 
Experiments with knockout mice, have shown that targeted disruption of genes in the 
VEGF system, cause intrauterine death of embryos resulting in an inability of these 
animals to produce live offsprings (Fong et al., 1995; Carmeliet et al., 1996).  Carmeliet 
et al. (1996) reported abnormal blood vessel formation in heterozygous and homozygous 
VEGF-deficient embryos resulted in death of the embryos at mid-gestation.  Mice 
embryos with a VEGFR-1 (Flk-1) gene disruption die on embryonic day 8.5 as a result of 
aberrant blood vessels formation (Fong et al., 1995).  Although endothelial cells develop 
in these animals, their rearrangement into small vessels does not occur.  KDR expression 
on the surface of hemangioblasts contributes to differentiation of these cells into 
haematopoietic and endothelial cells.  Embryos with KDR gene disruption are not able to 
produce mature haematopoietic cells and endothelial cells (Krussel et al., 2003).   
 
Other receptors are also expressed on the endothelial cells and specifically bind to VEGF.  
VEGFR-3 is found predominantly on the lymphatic endothelial cells (Bates and Harper, 
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2003).  Recently, neuropilin-1 (NRP1) has been identified as a neuronal receptor in 
developing nervous tissue.  However, it has been shown that the VEGF 165 isoform, (one 
of the most predominant isoforms in the human uterus) binds to the NRP1 receptor (Day 
et al., 2004).  Studies on NRP1 knockout mouse showed cardiovascular abnormalities 
which caused death of the embryos on days 10.5-12.5 in utero (Kitsukawa et al., 1997). 
    
It has also been reported that another angiogenic factor, angiopoietin (angiopoietin-1 and 
angiopoietin-2) coordinates the expression of VEGF.  Angiopoietin-1 upregulates and 
coordinates VEGF effects on vascular permeability and angiogenesis, while angiopoietin-
2 acts as an antagonist by suppressing angiogenesis (Matsumoto et al., 2002).  However, 
before and during the attachment reaction in mice, vascular permeability and 
angiogenesis are predominantly regulated by VEGF expression (Matsumoto et al., 2002).  
Studies in the human endometrium suggested that amongst several endometrial growth 
factors, only VEGF stimulates growth of the capillaries in the decidual endometrium 
(Zhang et al., 1998; Demir et al., 2004).  Angiopoietins together with VEGF are 
important in these processes during decidualization following implantation (Matsumoto 
et al., 2002).  
 
Oestrogen and progesterone induce VEGF expression in the rodent uterus (Hyder and 
Stancel, 1999).  Oestrogen and oestrogen agonists such tamoxifen, induce expression of 
VEGF in the rat uterus, and it appears that VEGF is oestrogen-receptor mediated (Hyder 
et al., 1996).  Similarly, other studies suggest that progesterone also induces VEGF 
expression in the rodent uterus (Cullinan-Bove and Koos, 1993).  
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1.5.2 Cyclooxygenase2 (COX2) 
Cyclooxygenase1 (COX1) and COX2 are the rate-limiting enzymes that convert 
arachidonic acid into prostaglandins (PGs).  Arachidonic acid is converted into 
prostaglandin H2 (PGH2), which is the precursor for a variety of prostaglandins (PGs) 
important in normal physiological and pathological conditions (Markenson, 1999).  The 
principal bioactive PG metabolites are: prostaglandin E2 (PG E2), PGF2, PGD2, PGI2 and 
TXA2 (Breyer et al., 2000).  In rodents, prostaglandins are implicated in the events in 
early pregnancy (Kennedy, 1977; Kennedy and Lukash, 1982; Ni et al., 2002; Ni et al., 
2003).  Amongst biologically active PGs, PGE2 and PGI2 are the most predominant 
metabolites involved in the events in the rodent uterus in early pregnancy (Lim et al., 
1999).  PGs mediate diverse events in various tissues by binding to a set of cell surface 
receptors (Lim and Day, 1997).  The surface receptors for PGE2, one of the predominant 
PGs in the uterus, are Ep1, Ep2, Ep3 and EP4 (Yang et al., 1997).  Genes of these receptors 
are expressed in a spatio-temporal manner, suggesting PGE2’s role in preparation of the 
uterus for implantation as well as decidualization (Lim and Day, 1997).   
 
It has been previously suggested that an increase in PGs and expression of COX1 prior to 
implantation, mediates uterine oedema and luminal closure which are important for the 
attachment reaction in rodents (Kennedy, 1977; Chakraborty et al., 1996).  Chakraborty 
et al. (1996) stated that PGs produced at the site of implantation by COX2 are important 
for localized increased vascular permeability and the attachment reaction, and are 
involved in angiogenesis for the establishment of the placenta.  In addition, it has been 
shown that PG levels are higher in the endometrium at implantation sites compared to the 
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inter-implantation sites in many species (Bany and Kennedy, 1997) supporting the 
importance of their involvement in implantation. 
 
The two isoforms, COX1 and COX2 are encoded by two separate genes, Ptgs1 and Ptgs2 
(Smith et al., 2000).  The expression of COX1 is more constant as it is important in 
regulating cell function, while COX2 expression is up-regulated in response to various 
stimuli (Das et al., 1999).  In mice, COX1 is expressed in the luminal epithelial cells and 
glandular cells on the morning of day 4 of pregnancy but is not detectable in these cells at 
the time of the attachment reaction (Dey et al., 2004). COX2 is expressed in the luminal 
epithelial cells and subepithelial stromal cells at the site of implantation on day 5 of 
pregnancy in mice (Dey et al., 2004). 
  
Experiments with COX1-deficient mice show that the females are fertile with a specific 
parturition defect, while COX2-deficient females are infertile and show abnormalities in 
ovulation, fertilization, implantation and decidualization (Matsumoto et al., 2001).  
Cheng and Stewart (2003) recently reported that wild-type blastocysts, following transfer 
into COX2 deficient mice, implant and develop successfully to term.  These animals 
however, show a reduction in decidual growth when compared to the wild-type mice, but 
are restored to their normal growth rate after 24-36h.  These results suggest that COX2 is 
required for the induction of other factors mediating angiogenesis (Cheng and Stewart, 
2003).  Specifically, VEGF is important for the process of vascular permeability and 
angiogenesis in the uterus, both in rodents and humans.  Thus, it is possible that during 
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the initial stages of decidualization, COX2 is required for induction of VEGF expression 
(Cheng and Stewart, 2003). 
 
Since exogenous hormones cause an increase in oestrogen levels and alter the 
progesterone:oestradiol ratio, which subsequently cause unsatisfactory changes in the 
uterine morphology and aberrant expression of implantation related genes, it would be of 
interest to see whether hyperstimulation affects COX2 and VEGF during the peri-
implantation and thus the receptivity of the uterus for blastocyst implantation.  
   
1.6 AIM OF THE STUDY 
The aim of this study was:  
1. To investigate the expression of VEGF and COX2 in the normal rat uterus during 
the peri-implantation period 
2. To determine the effect of hyperstimulation on the expression of VEGF and 
COX2  
3. To provide a better understanding of the use of hyperstimulation on these two 
important mediators of implantation during early pregnancy. 
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2.0MATERIALS AND METHODS 
 
2.1 Animals 
Animal ethics clearance for this experiment was granted by the Animal Ethics 
Committee, University of the Witwatersrand (AESC NO: 2004/100/4).  Adult, virgin 
female Sprague-Dawley rats (n=36) and two male rats of proven fertility were used for 
the experiment.  Animals were obtained and housed in the Animal Unit of the University 
of the Witwatersrand.  The animals were housed in an environment with a controlled 
temperature of 22°C and a 12h light and 12h darkness cycles.  The animals were fed with 
rat cubes and water ad libitum.   
 
Vaginal smears of the female rats were taken daily until a regular 4-day oestrous cycle 
had been established.  The smears were fixed in alcohol and stained using Shorr’s stain 
(Appendix 1).  Stages of the oestrous cycle were assessed according to Kent and Smith 
(1945) (Appendix 2). The phases of the oestrous cycle are: oestrus, metoestrus, dioestrus 
and pro-oestrus.  Animals showing at least three consecutive regular 4-day cycles were 
used for the experiment. 
 
The animals were divided into two groups: 
Group 1 – Experimental (hyperstimulated):  
Female rats (n=18) received an intra-peritoneal injection of 20i.u. of  follicle stimulating 
hormone (FSH) (Folligon, Intervet, Johannesburg) at mid-day of dioestrus followed by an 
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intraperitoneal injection of 20i.u. of human chorionic gonadotropin (hCG) (Chorulon, 
Intervet, Johannesburg) 24h later, at late dioestrus (Stein et al., 1993) 
Group 2 – Control (normal pregnant):  
Female rats (n=18) received an intraperitoneal injection of sterile saline at the same stage 
of the oestrous cycle as the hyperstimulated animals received exogenous hormones. 
Control and experimental females were placed with a fertile male on the afternoon of pro-
oestrous to mate. 
 
On the morning following mating, female rats were examined to assess the presence of a 
mucous plug.  Vaginal smears were examined for the presence of spermatozoa for 
confirmation of successful copulation.  The day following mating was taken as day 0.5 of 
pregnancy following the work of Kramer et al. (1993).  The timing of pregnancy in the 
present study differs to other studies where the morning after mating was taken as a day 1 
of pregnancy (Enders and Schlafke, 1967; Psychoyos, 1973; Lim et al., 1997).  The 
reason for this is that the rats mate in the early evening and the females were killed for 
the experiment in the early morning of the following day of pregnancy.  This corresponds 
to approximately 12 hours after mating or 0.5 days of pregnancy.  Thus, in the other 
relevant published studies day 1 will correspond to day 0.5 in the present study.  Vaginal 
smears were taken daily until the day of sacrifice to confirm the maintenance of 
pregnancy. 
 
Animals were anaesthetized with 0.6 ml of Chanazen (Centaur Labs, Johannesburg, SA) 
and 0.24 ml of Ketamine (Centaur Labs, Johannesburg, SA) on days 4.5, 5.5 and 6.5 of 
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pregnancy (n=6 control and n=6 hyperstimulated per group, per day of sacrifice).  Blood 
samples from heart punctures of these animals were collected and placed in sterile 
heparin tubes.  The blood was immediately centrifuged and the plasma was stored at -
70°C until assayed for oestradiol and progesterone levels by ELISA (enzyme-linked-
immunosorbent assay).       
 
An incision through the anterior abdominal wall was carried out in order to view the 
inferior vena cava, ovaries and uterine horns.  A 1% pontamine blue solution (a high 
molecular weight dye) was injected into the inferior vena cava and was allowed to 
circulate in the anesthetized animal for 10-15 minutes (Psychoyos, 1973).  Due to 
vascular permeability and leakage of the pontamine blue into the surrounding tissue, blue 
bands were noted at the site of the implanting blastocysts (Psychoyos, 1973).  The uterine 
horns of the animals were then removed, dissected from the surrounding tissue and 
washed with phosphate buffered saline pH 7.6 (PBS) (Appendix 3) to remove blood.  
Regions of the uterine horns showing blue bands (implantation sites) were separated from 
the non-implantation sites by sharp dissection for total protein extraction and Western 
blot analysis.  Uterine horns of animals not showing blue bands after pontamine blue 
injections were sectioned in pieces of approximately 5-10 mm in length from different 
regions of the uterine horns. 
  
Dissected pieces of tissue were fixed in 10% neutral buffered formalin (Appendix 4).  An 
automatic tissue processor (Shandon Citadel 1000) was used to dehydrate tissue through 
graded alcohols and chloroform followed by embedding the tissue in paraffin wax.  
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Tissue blocks were utilized for routine histology and immunohistochemical localisation 
of specific antigens. Following removal of the uterine horns the animals were killed by 
exsanguination. 
 
2.2 Progesterone and oestradiol ELISA 
Progesterone and oestradiol were quantitatively determined in the plasma of these 
animals by using an Estradiol (E2) Enzyme immunoassay test kit (Linear Chemicals, 
Spain) and a Progesterone enzyme immunoassay test kit (Linear Chemicals, Spain) for 
raw data see Appendix 5).  ELISA (enzyme-linked-immunosorbent assay) is based on the 
competition principle in the microtitre plate.  An unknown amount of antigen 
(progesterone or oestradiol) present in the sample and a fixed amount of enzyme-labelled 
antigen compete for the constant amount of rabbit anti-progesterone or anti-oestradiol.  
Each blood sample obtained from the control and experimental animals was assayed in 
duplicate.  According to the manufacturer’s recommendation 25 µl of standards, 
specimens and controls were dispensed into appropriate wells on the microtitre plate.  
Progesterone or oestradiol-HRP conjugate reagent (100 µl) and 50 µl of rabbit anti-
progesterone or rabbit anti-oestadiol reagent were added to each well and mixed 
thoroughly.  Incubation was carried out for 90 minutes at room temperature.  After 
incubation, the wells were washed with distilled water to stop the competition reaction.  
After the substrate solution was added and incubated at room temperature for 20 minutes 
the reaction was stopped by adding 100 µl of stop solution to each well.  The plate was 
gently mixed to allow a change from a blue colour to yellow.  The concentration of 
antigen was inversely proportional to the optical density measured (read at 450 nm). The 
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standard curve was obtained by plotting the concentration of the standard versus the 
absorbance and was used to calculate the unknown sample concentration. 
 
2.3 Histology 
Sections 4µm thick, prepared from the paraffin wax blocks were placed on silane (3 
Aminopropyl triethoxy-silane, obtained from Sigma-Aldrich Co, USA) dipped glass 
slides (Appendix 6).  Every sixth section of each block was deparaffinised in xylene and 
rehydrated in a series of graded alcohols.  Sections were than stained with haematoxylin 
and eosin (Appendix 7) in order to investigate the morphology of the uteri at different 
stages of pregnancy.  The haematoxylin and eosin stain is a widely used histological 
stain.  This staining method, demonstrates a large number of different tissue structures 
(Bancroft and Gamble, 2002).  The haematoxylin component stains cell nuclei blue-black 
(basophilic), whilst the eosin stains cell cytoplasm and connective tissue fibres in shades 
of pink, orange and red (eosinophilic) (Bancroft and Gamble, 2002). 
 
2.4 Immunohistochemistry  
Formalin-fixed, paraffin embedded tissues were sectioned at 4µm.  Fixation in formalin, 
as well as paraffin embedding of tissue is known to allow substantial changes in the 
antigen epitopes (the structural part of an antigen which reacts with an antibody).  These 
changes in the antigen epitopes can lead to complete loss of immunoreactivity by the 
antigen or the “masking” of the antigen (Boenisch, 2001).  Restoration of 
immunoreactivity or antigen unmasking (antigen retrieval) can be achieved by 
application of heat for varying lengths of time to the sections in an aqueous medium 
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(Boenisch, 2001).  In the present study, antigen retrieval of the tissue was carried out by 
microwaving the sections in citrate buffer at pH6 (Appendix 8) twice, for 5 minutes. 
Sections were than incubated with 3% hydrogen peroxide for ten minutes at room 
temperature in order to block endogenous peroxidase activity.  The immunostaining 
procedures were different for the two antibodies utilized following incubation with 
hydrogen peroxide, and are explained separately in the text below. 
 
 2.4.1 VEGF immunostaining 
Sections were incubated with 1% rabbit serum in TRIS-buffered saline pH 7.6 (Appendix 
9) for 10 minutes at room temperature for blocking non-specific binding.  Primary mouse 
monoclonal VEGF antibody (sc-7269) was obtained from Santa Cruz Biotechnology.  A 
series of dilutions were carried out to determine the optimal suitable concentration of the 
antibody.  Sections were then incubated with the primary (VEGF) antibody at a dilution 
of 1:100 overnight at 4°C.  After washing the sections twice for 5 minutes in Tris-
buffered saline (TBS), a secondary rabbit anti-mouse antibody (Dako), was diluted in 
TBS (1:300) and then applied for 30 minutes at room temperature.  Sections were washed 
twice for 5 minutes and a streptavidin horseradish peroxidase complex (Dako, Denmark) 
at a dilution of 1:300 was applied for 30 min at room temperature.  The positive reaction 
was identified by the chromagen, diaminobenzidine (DAB) (Dako, Denmark).  After 
incubation with DAB for 5 minutes, sections were washed in tap water for 5 minutes.  
Sections were then counterstained in haematoxylin for 20 seconds and dehydrated in 
graded alcohols and xylene, before coverslipping in entellan. 
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2.4.2 COX2 immunostaining 
A primary goat polyclonal COX2 antibody (sc-1747; Santa Cruz Biotechnology USA) 
and Immunostaining kit (sc-2053 Immuno Cruz Staining System) was used for COX2 
immunoassaying. 
          
Sections (4µm in thickness) were incubated for 20 minutes at room temperature in 1-2 
drops of serum block provided in the Immunostaining kit, followed by removal of the 
excess serum block.  Primary goat polyclonal COX2 antibody at a dilution of 1:100 was 
applied to the sections for two hours at room temperature.  After washing in TBS with 
0.05% Tween 20 three times for 5 minutes, secondary biotinulated antibody (provided in 
the Immunosraining kit) was applied for 30 minutes at room temperature.  Sections were 
washed three times for 5 minutes in TRIS-buffered saline with 0.05% Tween 20 and 
incubated with streptavidin HRP complex for 30 minutes at room temperature.  Sections 
were washed 3 times in TBS with 0.05% Tween 20, and than incubated with DAB for 5 
minutes. Sections were than washed in tap water for 5 minutes, counterstained in 
haematoxylin for 20 seconds and dehydrated in graded alcohols and xylane, before 
coverslipping in entellan.  The sections were than analyzed for VEGF and COX2 
immunolocalization by light microscopy using the Zeiss Axioscope microscope 
(Axioscope 2, MOT, Carl Zeiss, Germany). The images were captured by digital camera 
(Sony 3 CCD). 
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2.4.3 Controls for immunohistochemistry 
Negative controls were prepared using tissue sections adjacent to the sections showing 
immunolocalization of antibodies. In the first instance the primary antibodies were 
replaced with TBS and in the second negative control, the secondary antibodies were 
replaced with TBS. 
  
An absorption control (pre-absorbtion of the respective antibody with its antigen, and 
substituted for the primary antibody) was not carried out as the VEGF and COX2 
antigens were not available commercially.    
 
Formalin-fixed paraffin embedded breast carcinoma tissue was prepared by the same 
procedure as mentioned above and used as a positive control for VEGF immunostaining. 
Human lung carcinoma tissue was used as a positive control for COX2 
immunolocalization.  Human Ethics Committee approval for the use of these tissues was 
granted by the Human Ethics Research Committee of the University of the Witwatersrand 
(M050521).  
 
2.5 Protein extraction 
Dissected pieces of uterine tissue approximately 5-10 mm in length were further sliced 
with sterile scissors and placed in a clean homogenizer with 5 ml of homogenising buffer 
(Appendix 10) with DTT stock and protease inhibitor cocktail stock (Sigma-Aldrich Co, 
USA).  Homogenizing was carried out slowly, letting in as little air as possible, to prevent 
foaming.  The homogenized tissue was centrifuged at 12 000 rpm for 20 minutes at 4˚C, 
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followed by the removal of supernatant.  Supernatant was aliquoted in 200µl aliquots and 
stored at -70˚C until used. 
 
2.6 Protein Concentration (Lowry protein assay)   
Total protein determination from the homogenized tissue was carried out by the Lowry 
protein assay. The assay is based on complex formation of the protein with copper. 
Adding folin phenol reagent results in binding to the protein and changes the colour from 
yellow to blue. 
  
Bovine serum albumin (BSA) was used as the standard.  A working solution was made 
up of 2000 µg BSA in 1000µl of PBS pH 7.4.  Serial dilutions of two folds were carried 
out in triplicate up to a dilution of 1:31.25.  Extracted protein samples of control and 
hyperstimulated animals were diluted in PBS (1:20) prior to testing.  ELISA microtiter 
plates were used for the test.  In respective wells of the microtiter plate, 50 µl of the 
diluted protein extract sample and 200 µl of reagent A (Appendix 11) were added and 
incubated on a shaker for 10 minutes at room temperature.  Reagent B (50 µl) (Appendix 
12) was added followed by incubation for 30 minutes on a shaker.  Labsystems Multiskan 
Ascent (Amersham Pharmacia Biotech, Buckinghamshire, UK) a microtiter well reader 
was used to read absorbance at 690 nm. A standard curve was created by plotting the 
absorbance values of the BSA standards against their concentrations (Fig. 3).  The protein 
concentration in the sample was than calculated automatically of the graph multiplied by 
the dilution factor (for raw data see Appendix 13).  
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Fig. 3:  Standard curve for Bovine Serum Albumin (BSA) at known 
concentrations in g/ml at an absorbance of 690 nm  
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2.7 Electrophoresis 
Protein separation was carried out on a 10% SDS-polyacrylamide gel (sodium dodecyl 
sulphate) (Appendix 14) in a Hoeffer Mighty Small Electrophoresis Unit (Amersham 
Pharmacia Biotech, Buckinghamshire, UK).  The separating gel was allowed to set for 
approximately 30 minutes before the loading of samples. 
  
The lower and upper buffer chambers of the electrophoresis unit were filled with 
electrophoresis tank buffer (Appendix 15). The wells of the separating gel were rinsed 
three times with the tank buffer to remove any unpolymerized gel solution.  A Hamilton 
Syringe (Hamilton Company Incorporated, Whittier, California, USA) was used to load 
the molecular weight marker, positive control or protein samples to the wells of the 
separating gel.  Two types of molecular weight markers were used.  Some of the gels 
were loaded with wide range molecular weight marker (Sigma-Aldrich Co., USA; range 
6.5-205kDa) and for a few gels, The PageRuler Prestained Ladder Plus (Fermentas, Life 
Sciences; range 10-250kDa) a highly purified coloured molecular weight marker, was 
available.  The first well of the separating gel was loaded with 4µl of a molecular weight 
marker.  The second well was loaded with a positive control consisting of 10µl of the 
whole cell lysate (sc-2210 for VEGF or sc-2211 for COX2, Santa Cruz Biotechnology, 
CA, USA).  The other consecutive wells were loaded with concentrated sample and 
sample diluted 1:10 and 1:20 in order to produce band representing VEGF or COX2 in 
relation to the molecular weight marker. The example of sample dilution 1:10 is as 
follows: 10µl of neat protein extraction, 40µl of TBS pH 7.6 and 50µl of transfer buffer 
containing SDS, ß mercaptoethanol and bromophenol blue (Appendix 16).   The positive 
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control samples and respective protein samples were boiled for 90 seconds, prior to 
loading in the wells of the gel. 
  
The system was connected to an electric power pack (Consort E452; Separation 
Scientific, Honeydew, South Africa).  The separation of the proteins was carried out at a 
constant current of 25mA for approximately one hour.  The movement of the protein was 
closely monitored.  After the separation of the protein, the gels were dipped in the 
Towbin buffer (Appendix 17) for 10 minutes at room temperature to stabilize. One gel 
was incubated with Commasie stain (Appendix 18) overnight.  Destaining of the gels 
with destain 1 and 2 (Appendix 19) was carried out in order to visualize the bands of 
separated proteins and to determine the band of interest in correlation with the molecular 
weight marker.  
 
2.8 Western blot 
A second gel was used for Western blotting.  Separated protein was transferred to a 
nitrocellulose membrane (Hybond – ECL, Amersham Pharmacia Biotechnology, UK). 
The nitrocellulose membrane was cut to the size of the gel and soaked in transfer Towbin 
buffer (Appendix 17).  The gel was laid out in a “sandwich” consisting of a sponge and 
double filter paper, the gel with the separated proteins, a nitrocellulose membrane, 
another double filter paper and sponge.  The gel was placed facing the side of the cathode 
(negative) tray as the transfer occurs from the negative to the positive side with electric 
current.  The transfer of proteins was carried out in Hoeffer Western blotting transfer 
equipment (Hoeffer Scientific Instruments, San Francisco, USA) filled with cold Towbin 
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buffer.  The electric current was set on 20V and left overnight at 4˚C.  After successful 
transfer, the membrane was washed twice for 5 min each in TBS with Tween 20 (Merck, 
Germany). 
 
The membrane was blocked in TBS with 5% non-fat milk for one hour at room 
temperature. Incubation with primary VEGF antibody (various dilution were probed: 
1:500; 1:750; 1:1000) was carried out overnight at 4˚C. For COX2, the primary antibody 
incubation was carried out for 2 hours at room temperature (dilution 1:750 or 1:1000). 
Incubation with the primary antibody was followed by a washing step. The membranes 
were washed twice for 5 minutes with TBS with Tween 20 at room temperature. 
Incubation with secondary rabbit anti-mouse HRP (Dako) diluted 1:1000 in 5% non-fat 
milk with Tween 20 was applied for 45 minutes at room temperature. Secondary COX2 
antibody rabbit anti-goat HRP (Santa Cruz Biotechnology) diluted 1:1000 in 5% non-fat 
milk with Tween 20 was applied for 45 minutes at room temperature. After washing the 
membranes in TBS with Tween 20 three times for 5 minutes each, and once for 5 minutes 
in TBS alone, the bands were detected by adding POD (BM Blue POD substrate, 
precipitating, Roche Diagnostics, Indianapolis, US) for 5 minutes at room temperature. 
The reaction was stopped with distilled water and the membrane allowed to dry.  
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3.0 RESULTS 
 
3.1 Oestradiol ELISA 
The summary statistical values for the ELISA oestradiol concentrations are shown in 
Table 3.1 for the control rats and Table 3.2 for the hyperstimulated animals at  4.5, 5.5 
and 6.5 days of pregnancy.  The oestradiol concentrations with standard deviations for 
both control and hyperstimulated animals are shown in Figure 4.  Values of oestradiol 
concentrations are given in pg/ml. 
 
In the control animals, the oestradiol concentrations increased from 4.5 days of 
pregnancy through 5.5 days and 6.5 days of pregnancy.  In the hyperstimulated rats, 
oestradiol concentrations were higher at 5.5 days when compared to the 4.5 days 
hyperstimulated rats and then markedly decreased on day 6.5 of pregnancy compared to 
the concentrations of oestradiol at 5.5 days in the hyperstimulated rats.  On day 5.5 in the 
hyperstimulated rats, an extremely high oestradiol concentration was recorded (66.60 
pg/ml) in one of the animals.  However, the outcome of the results did not change in the 
case when statistical analysis was carried out without the result of that particular animal.  
 
Statistically significantly higher oestradiol levels were found only between the control 
and hyperstimulated animals at 6.5 days of pregnancy. 
 




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Table 3.1 
 
Summary of the statistical values of oestradiol concentrations  
in the control animals 
 
 
Factor Hormone Days of 
pregnan
cy 
Number of 
animals 
Mean 
pg/ml 
SD Min Max 
Control Oestradiol 4.5 5 21.28 11.23 12.40 40.80 
Control Oestradiol 5.5 6 22.68 8.39 12.10 32.90 
Control Oestradiol 6.5 6 32.52 13.65 19.50 51.90 
 
 
 
 
Table 3.2 
 
Summary of the statistical values of oestradiol concentrations in the 
hyperstimulated animals 
 
 
 
 
Factor Hormone Days of 
pregna
ncy 
Number of 
animals 
Mean 
pg/ml 
SD Min Max 
Hyper-
stimulated 
Oestradiol 4.5 6 28.46 8.14 19.50 41.10 
Hyper-
stimulated 
Oestradiol 5.5 5 37.86 16.42 26.20 66.60 
Hyper-
stimulated 
Oestradiol 6.5 6 17.87 6.46 12.90 29.90 
 
 
All values are oestradiol concentrations in pg/ml.  
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3.1.1 Statistical analysis for oestradiol concentration 
The unpaired Student’s “t” test was used to statistically analyse the oestadiol mean 
concentrations between control animals at different stages of pregnancy as well as  
between control and hyperstimulated animals at different stages of pregnancy. The data 
were also log-transformed before calculating the p values. However, the p values 
obtained after log transformation were similar and the outcome of the results did not 
change.  
 
No statistically significant differences for oestradiol were found between the control 
animals.  However, significantly higher oestradiol levels were found between the 5.5 and 
6.5 day hyperstimulated animals (p=0.022). 
 
When oestradiol concentrations were compared between the 4.5 day control and 4.5 day 
hyperstimulated animals, this was not statistically significant (p=0.250). 
 
At 5.5 days of pregnancy, a comparison between the mean oestradiol concentrations in 
the control and the hyperstimulated animals was not statistically significant (P=0.118). 
 
However, at 6.5 days of pregnancy statistically significantly higher mean oestradiol 
concentrations were found in the control animals compared to the hyperstimulated 
animals (P=0.039).  
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Fig. 4:   Graph showing plasma concentrations and standard deviations of 
oestradiol in the control and hyperstimulated animals. All 
concentrations are in pg/ml. 



 37 
3.2. Progesterone ELISA 
 
The summary of the statistical values for progesterone concentrations obtained from 
control animals is shown in Table 3.3 and for hyperstimulated animals in Table 3.4, at  
4.5, 5.5 and 6.5 days of pregnancy. The progesterone concentrations with standard 
deviations for both control and hyperstimulated animals are shown in Figure 5.  Values of 
progesterone concentrations at 4.5, 5.5 and 6.5 days of pregnancy are given in ng/ml. 
    
The mean progesterone concentrations increased in the 5.5 day control animals compared 
to the control animals at 4.5 days, while a slight decrease of progesterone was noticed at 
6.5 days of pregnancy.  In the hyperstimulated animals, the progesterone levels increased 
from 4.5 days through 5.5 days and 6.5 days of pregnancy. 
 
Progesterone levels were higher in the hyperstimulated animals compared to the control 
animals at all stages of pregnancy examined.  However, a statistically significantly higher 
progesterone concentration was found only between the control and the hyperstimulated 
animal groups on day 6.5 of pregnancy.       
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Table 3.3 
 
Summary of the statistical values for the progesterone concentrations  
in the control animals 
 
 
Factor Hormone Days of 
pregnancy 
Number Mean SD Min Max 
Control Progesterone 4.5 6 22.51 6.04 11.90 28.90 
Control Progesterone 5.5 6 25.36 5.06 18.30 30.78 
Control Progesterone 6.5 6 23.46 5.00 16.10 31.30 
 
 
 
 
Table 3.4 
 
Summary of the statistical values for the progesterone concentrations in the 
hyperstimulated animals 
 
 
 
 
Factor Hormone Days of 
pregnancy 
Number Mean SD Min Max 
Hyper-
stimulated 
Progesterone 4.5 6 25.45 4.50 19.10 31.33 
Hyper-
stimulated 
Progesterone 5.5 5 32.06 7.70 24.30 44.30 
Hyper-
stimulated 
Progesterone 6.5 7 33.07 4.97 26.20 39.20 
 
 
All values are progesterone concentrations in ng/ml.  
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3.3.1 Statistical analysis for progesterone concentration  
The unpaired Student’s “t” test was used to compare progesterone concentrations 
between control animals at consecutive days of pregnancy, the same for the 
hyperstimulated animals at consecutive stages of pregnancy and between the pregnant 
and hyperstimulated animals at different stages of pregnancy. Data were also log-
transformed before calculating the p values, as had been done with oestradiol data. 
However, the p values were similar and the outcome of the results did not change.  
  
No statistically significant differences for the progesterone concentrations were recorded 
in either the control or hyperstimulated animals. 
  
When progesterone concentrations were compared between 4.5 day control and 4.5 day 
hyperstimulated animals, these were not statistically significant (p=0.362). 
 
No statistically significant differences were recorded between control and 
hyperstimulated animals at 5.5 days of pregnancy (p=0.213).    
 
However, the progesterone concentrations were statistically significantly higher in the 
hyperstimulated animals compared to the control animals at 6.5 days of pregnancy (p= 
0.006).  
 
 

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Fig. 5:    Graph showing plasma concentrations and standard deviations of 
progesterone in the control and hyperstimulated animals. All values 
are progesterone concentrations in ng/ml.  
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3.3. Non-parametric Mann-Whitney test 
 
In addition to statistical analysis using the Student’s “t” test, a non-parametric Mann-
Whitney test was used in order to determine possible statistically significant differences 
with regards to the progesterone and oestradiol concentrations between control and 
hyperstimulated animals at different stages of pregnancy.  These statistical results were 
then compared with the outcome of the Student’s “t” test. The outcome was the same in 
both statistical analyses.  In other words, no significant statistical differences were found 
between control and hyperstimulated groups of animals for both progesterone and 
oestradiol concentrations at 4.5 and 5.5 days of pregnancy.  However, significant 
statistical differences were evident between control and hyperstimulated animals at 6.5 
days of pregnancy for both progesterone and oestradiol. 











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3.4. Progesterone:Oestradiol (P:E2) ratio 
 
The progesterone:oestradiol ratio (P:E2 ) was calculated first for every individual animal 
in each group, followed by the calculation of the group P:E2 ratio. The group P:E2 ratio 
was calculated by dividing the mean progesterone concentration by the mean oestradiol 
concentration of the control animals at 4.5 or 5.5 or 6.5 days of pregnancy.  The ratio was 
also calculated in the hyperstimulated animals at the same stages of pregnancy.  The 
summary of the progesterone-oestradiol ratio is given in Table 3.5. 
 
 
Table 3.5 
 
  Summary of the P:E2 ratio of the control and hyperstimulated animals. 
 
Day and Factor Progesterone Oestrogen P:E2 
4.5 control 22.51 21.28 1.2352 
5.5 control 25.36 22.68 1.2177 
6.5 control 23.46 32.52 0.7977 
4.5 hyperstimulated 25.45 28.46 0.9490 
5.5 hyperstimulated 32.06 37.86 0.9454 
6.5 hyperstimulated 33.07 17.87 2.0693 
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Statistical analysis for P:E2 was carried out using the F-test of variance, Student’s “t” test 
and the Welch test (non-parametric test of uniqual variance).  
  
At 4.5 days and 5.5 days of pregnancy the P:E2 ratio was higher in the control animals 
than in the hyperstimulated animals at the same day of pregnancy.  However, it was not 
statistically significant.  
 
At 6.5 days in the control animals, the P:E2 was lower than in the hyperstimulated 
animals and this was statistically significant ( P < 0.01). 
 
 
 
 
      Table 3.6 
 
   Summary of statistical analysis for P:E2 ratio 
 
 
 Control Hyperstimulated    
Days mean (SD) mean (SD) F (P) t (P) Welch t (P) 
4.5 
1.2352 
(0.7117) 0.9490 (0.2765) 
6.6245 
(0.062) 
0.91367 
(0.385) 0.84747 (0.435) 
5.5 
1.2177 
(0.4168) 0.9454 (0.3556) 
1.7159 
(0.568) 1.2542 (0.238) 1.2542 (0.240) 
6.5 
0.7977 
(0.2776) 2.0693 (0.6083) 
4.8029 
(0.110) 
-4.6582 (0.000) 
* 
-4.6582 (0.002) 
* 
* Significant difference P < 0.01    
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Fig. 6: Progesterone:Oestradiol ratio (P:E2) in the control and hyperstimulated 
rats at 4.5, 5.5 and 6.5 days of pregnancy (NS = no significant difference 
between control and hyperstimulated groups; * = significant difference 
between groups: P < 0.01).   
 
 
 
 
 
P:E 2  RATIO
0 
0.5 
1 
1.5 
2 
2.5 
3 
4.5 5.5 6.5 
DAYS 
P:E 2 Control 
Hyperstimulated 
NS NS 
* 
 45 
3.5. General Observation 
The uterine horns and ovaries showed distinct gross morphological differences between 
the control and hyperstimulated animals.  Ovaries appeared larger and contained 
numerous follicles in the hyperstimulated animals (Fig. 8) compared to the control rats 
(Fig. 7). Implantation sites, stained blue with the pontamine blue technique, were present 
in the uterine horns of one control animal (three implantation sites) at 4.5 days of 
pregnancy. All other animals in both the control and hyperstimulated groups at 4.5 days 
of pregnancy did not show blue bands.  In all control animals on days 5.5 (Fig. 7) and 6.5 
of pregnancy, numerous implantation sites staining blue were evident (average 8-15 
implantation sites per animal).  However, only in two animals in the hyperstimulated 
group at 5.5 days of pregnancy, one possible implantation site in each animal was 
evident.  None of the hyperstimulated animals at 6.5 days showed blue bands. 
 
The uterine horns of the hyperstimulated animals at all stages of pregnancy were 
markedly dilated (Fig. 8), when compared to control animals at the same stage. 
 
 
 
 
 
 
 
 46 
3.6. Histology 
 
The histology of the ovaries and the uterine tissue of control and hyperstimulated animals 
were examined in order to analyse tissue morphology.  
 
The ovaries of the control animals at all stages examined (4.5, 5.5 and 6.5 days of 
pregnancy) contained numerous corpora lutea which were well developed (Fig. 9).  The 
ovaries of the hyperstimulated animals at all stages examined, contained numerous large 
secondary follicles. Corpora lutea were also present in the ovaries of the hyperstimulated 
animals, however, smaller compared to those of normal pregnant animals (Fig. 10).  
 
The surface of the uterine lumen in control animals at 4.5 days of pregnancy appeared 
smooth.  The luminal walls were in apposition at the antimesometrial end of the uterine 
lumen (region of the implanting blastocyst) (Fig. 11).  The luminal epithelial cells were 
simple cuboidal with oval nucleus, displaced from the base of the cell by the presence of 
vacuoles (Fig. 12).  Numerous microvilli covered the apex of the cells (Fig. 13).  Some of 
the cells in the subepithelial stroma adjacent to the luminal epithelial cells predominantly 
at the antimesometrial pole were round (indicating decidualization) and contained 
prominent round basophilic nuclei (Fig. 13).  Potential spaces were apparent between the 
stromal cells indicated oedema of the tissue as a result of vascular leakage.  However, the 
majority of the cells in the stroma were flat and fibroblastic and the tissue appeared 
compact.  
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Numerous glands were observed in the stroma.  Glandular cells were simple cuboidal 
with prominent large nuclei which were basally placed in the cell.  The presence of 
vacuoles was noted in the cytoplasm around the nucleus of the glandular cells (Fig. 13).  
 
The uterine tissue of hyperstimulated animals at 4.5 days of pregnancy showed distinct 
differences in the luminal epithelium and tissue morphology compared to the 4.5 day 
control animals.  The uterine lumen was markedly dilated and the mucosa was very 
folded (Fig. 14).  The luminal epithelial cells were simple columnar with large, oval, 
basally placed nuclei (Fig. 15). Vacuoles were not present in these cells.  The 
subepithelial stromal cells were flat and fibroblastic (Fig. 15). Numerous uterine glands 
were observed in the stroma.  The glandular lumen was dilated.  The glandular cells were 
simple cuboidal and contained large, basally placed nuclei (Fig. 16).  Vacuoles were 
absent from the cytoplasm of the glandular cells at 4.5 days of pregnancy in the 
hyperstimulated animals. 
  
The gross morphology of the uterine tissue at 5.5 and 6.5 days of pregnancy in control 
animals was similar to that of the tissue at 4.5 days of pregnancy in control animals.  The 
uterine lumen was smooth and the uterine walls were in apposition (Fig. 17).  However, 
histological changes of the uterine tissue were evident at 5.5 days of pregnancy.  The 
luminal epithelial cells were simple cuboidal in shape (Fig. 18).  The apical portions of 
these cells were covered with numerous microvilli.  Oval nuclei were placed towards the 
base of the luminal epithelial cells on the antimesometrial side, as vacuoles were not 
present in these cells (Fig. 18).  However, at the mesometrial side of the lumen, vacuoles 
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were present basally in the luminal epithelial cells, but were decreased in size.  Decidual 
cells were arranged in a distinct thick layer in the subepithelial stroma (primary decidual 
zone).  Numerous blood vessels were evident in the stroma.  Spaces between the decidual 
cells were evident and indicated the collection of extracellular fluid in the tissue (Fig. 18).  
Uterine glands were numerous in the stroma and were arranged in clusters.  The 
glandular cells remained simple cuboidal in shape.  Vacuoles were not present in the 
glandular cells in 5.5 day control animals. 
 
Uterine tissue of the hyperstimulated animals at 5.5 days showed similarities in 
morphology and histology to that of 4.5 day hyperstimulated animals.  The uterine lumen 
of these animals was markedly dilated and contained numerous mucosal folds (Fig. 19).  
The luminal epithelial cells were simple columnar with numerous microvilli on their 
apical border. Large nuclei were basally placed in the luminal epithelial cells (Fig. 20). 
Subepithelial stromal cells remained flat and fibroblastic.  Numerous glands arranged in 
clusters were present in the stroma (Fig. 20).    
 
On day 6.5 of pregnancy in the control animals, more extensive decidualisation was 
evident compared to that at 5.5 days.  Numerous stromal cells adjacent to the primary 
decidual zone were rounded and the stroma appeared oedematous.  This histological 
change was indicative of formation of a secondary decidual zone (Fig. 21).  The stromal 
blood vessels were numerous and were surrounded by decidual cells (Fig. 22).  At the 
antimesometrial side, the luminal epithelial cells showed distinct differences to those at 
the mesometrial side of the lumen.  At the mesometrial side of the uterine lumen, the 
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luminal epithelial cells were simple low cuboidal.  At the antimesometrial side, luminal 
epithelial cells were simple squamous (Fig. 22) and at the margin with the implanting 
blastocyst, the epithelium had disappeared allowing for contact of the blastocyst and 
decidua.      
 
Sections of uterine tissue of hyperstimulated animals on 6.5 days of pregnancy followed a 
similar pattern in morphology and histological appearance to that of 4.5 and 5.5 day 
hyperstimulated animals.  The uterine lumen contained numerous folds of the luminal 
epithelial cells and subepithelial stromal tissue (Fig. 23).  The luminal epithelial cells 
were simple columnar with large nuclei, basally placed in the cell.  The subepithelial 
stromal cells were fibroblastic (Fig. 24).  Numerous uterine glands were observed in the 
stoma. Glandular cells remain simple cuboidal and contained large basally placed nuclei 
(Fig. 24) without vacuoles in the cytoplasm. 
 







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3.3 Immunohistochemistry 
 
3.3.1 Controls for COX2 immunohistochemistry  
Human lung carcinoma was used as a positive control.  Sections of the lung carcinoma 
tissue expressed COX2 immunoreactivity in the cytoplasm of the lung carcinoma cells 
(Fig. 25). 
  
For the negative control, sections of the uterine tissue, in both control and 
hyperstimulated animals were used.  Sections adjacent to the sections of the uterine tissue 
which showed COX2 immunolocalization were incubated with TRIS buffered saline in 
place of either the primary or secondary antibody.  While the control tissue expressed 
immunolocalization of the respective protein (Fig. 26), the sections incubated with TRIS 
in the place of the primary antibody (Fig. 27a) or the secondary antibody (Fig. 27b) 
showed no evidence of COX2 protein expression.   
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3.3.2 Immunolocalisation of COX2 in control and hyperstimulated animals at 4.5, 
5.5 and 6.5 days of pregnancy  
 
Immunolocalization of COX2 was evident in the tissue of both control and 
hyperstimulated animals at different stages of pregnancy.  However, differences in the 
distribution of COX2 immunolocalization were evident between the two groups of 
animals. 
   
At 4.5 days of pregnancy in the control animals, COX2 immunolocalization was evident 
in the cytoplasm of the luminal epithelial cells, the subepithelial stromal cells and the 
glandular cells (Fig.28).  While the expression of COX2 was clearly evident in the 
luminal epithelial cells, only scanty cytoplasmic COX2 immunolocalization was noted in 
the glandular cells and the rounded stromal cells immediately adjacent to the luminal 
epithelial cells, predominantly at the antimesometrial side at 4.5 days of pregnancy.  
 
In the hyperstimulated animals at 4.5 days of pregnancy, intense immunolocalization of 
COX2 was evident in the cytoplasm of the luminal epithelial cells and less so, in the 
glandular cells.  However, COX2 immunolocalization was absent in the stromal cells 
(Fig. 29).  The luminal epithelial cells showed variable protein expression as some 
epithelial cells expressed highly intense COX2 immunolocalization compared with the 
other epithelial cells (Fig. 29). The majority of the luminal epithelial cells expressed more 
intense immunolocalization around the nucleus. Glandular cells expressed a lower 
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intensity of COX2 immunolocalization compared to the luminal epithelial cells, and this 
was evenly distributed in the cytoplasm (Fig. 29).  
 
At 5.5 days of pregnancy in the control animals, COX2 immunolocalisation was weakly 
present in the luminal epithelial cells (Fig.30).  It was less intense compared to that in the 
luminal epithelial cells of the animals at 4.5 days of pregnancy.  COX2 
immunolocalization was weakly present and evenly distributed in the glandular cells.  
Stromal decidual cells immediately adjacent to the luminal epithelial cells (primary 
decidual zone) expressed a stronger cytoplasmic COX2 localisation when compared to 
the 4.5 day control stromal tissue. 
  
In the hyperstimulated animals at 5.5 days of pregnancy, an uneven and often intense 
localization of COX2 was evident in the luminal epithelial cells (Fig. 31).  There was 
however an even, but very weak, distribution in the glandular cells (Fig. 31).  Stromal 
cells at 5.5 days in hyperstimulated animals did not show COX2 immunolocalization. 
 
At 6.5 days of pregnancy in the control animals, COX2 immunolocalization was not 
evident in the luminal epithelial cells which showed varying morphological appearances 
in the different regions of the lumen (Fig. 32).  The glandular cells expressed scanty 
cytoplasmatic COX2 immunolocalization.  However, the decidual stromal cells at 6.5 
days of pregnancy in the control animals showed strong immunolocalization of COX2 
which was particularly strongly localized around the nucleus of the decidual cells.  Also, 
the cells in the primary decidual zone showed stronger localization compared to the 
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decidual cells in the secondary decidual zone.  In the tissue sections containing an 
embryo, weak COX2 immunolocalization was evident in the embryonic cell mass (Fig. 
32).  
  
In the hyperstimulated animals at 6.5 days of pregnancy, strong expression of COX2 was 
evident in the simple high columnar luminal epithelial cells.  Stromal cells did not 
express COX2 localization at this stage of pregnancy (Fig. 33).  
 




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3.4.1 Controls for VEGF immunohistochemistry 
  
Sections of human breast carcinoma tissue were used as a positive control.  VEGF 
immunoreactivity was observed in the cytoplasm of the tumour cells (Fig. 34). 
  
For the negative control, sections of uterine tissue, in both the control and 
hyperstimulated animals, adjacent to the sections showing VEGF immunolocalization 
were incubated with TRIS buffered saline in place of either the primary or secondary 
VEGF antibody. While the experimental tissue expressed immunolocalization of the 
protein (Fig. 35), in the sections incubated with TRIS in place of the primary antibody 
(Fig. 36a) and the secondary antibody (Fig. 36b) no VEGF immunolocalization was 
present in any tissue compartment.  
 



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3.4.2 Immunolocalization of VEGF in control and hyperstimulated animals at 4.5, 
5.5 and 6.5 days of pregnancy 
  
Uterine tissue sections of control and hyperstimulated animals incubated with VEGF 
antibody showed differences in the distribution of VEGF immunolocalization in these 
two groups of animals at different stages of pregnancy. 
  
At 4.5 days of pregnancy in the control animals, VEGF immunolocalization was evident 
in the cytoplasm of the luminal epithelial cells, the glandular epithelial cells and the 
subepithelial stromal cells (Fig. 37).  Expression of VEGF was evident in the cytoplasm 
of the luminal epithelial cells, particularly in the basal part of the epithelial cells and 
surrounded the vacuoles which were present (Fig. 37).  The cytoplasm of the glandular 
cells showed evenly distributed VEGF immunolocalization.  In the subepithelial stroma, 
only the rounded cells indicating decidualization showed distinct cytoplasmic VEGF 
immunolocalization, while the fibroblasts did not show immunolocalization (Fig.37).  
VEGF immunolocalization was present in the stromal blood vessels as well. 
 
A difference in distribution of VEGF immunolocalization was evident in the 
hyperstimulated uterine tissue compared to the control tissue at 4.5 days of pregnancy. 
While VEGF was evident in the cytoplasm of the luminal epithelial cells and glandular 
cells (Fig. 38) at 4.5 days in the hyperstimulated animals, the stromal cells did not show 
localization of the protein (Fig.38).  VEGF was highly intense and evenly distributed in 
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the apical portions of the tall simple columnar luminal epithelial cells.  In addition, the 
uterine glandular cells showed intense cytoplasmic VEGF immunolocalization (Fig. 38). 
 
Distribution of VEGF immunolocalisation in control animals at 5.5 days of pregnancy 
followed a similar pattern of expression to the control animals at 4.5 days of pregnancy. 
However, the luminal epithelial cells, the glandular and decidual stromal cells of the 5.5 
day control animals expressed a much higher intensity of VEGF localization compared to 
those of 4.5 day pregnancy (Fig. 39). 
  
Hyperstimulated animals at 5.5 days of pregnancy expressed VEGF localization in the 
luminal epithelial cells and glandular cells.  The intensity of VEGF imunolacalization 
was similar to that at 4.5 day hyperstimulated animals. The stromal cells at this stage, as 
at 4.5 days, did not show immunolocalization (Fig. 40).  
 
At 6.5 days in the control animals, VEGF was differently localized when compared to the 
control animals at 5.5 days of pregnancy.  These differences were particularly evident in 
the distribution of VEGF in the luminal epithelial cells and stromal cells. The luminal 
epithelial cells at the antimezometrial side, immediately adjacent to the embryo did not 
show VEGF localization, while localization was evident in the luminal epithelial cells at 
the mesometrial side of the lumen (Fig. 41).  In addition, at the antimesometrial side 
some of the cells of the embryo, which appeared to be trophoblastic cells, showed intense 
immunolocalization of VEGF (Fig. 42).  VEGF was also localized to the embryonic cells 
(Fig. 42).  Decidual stromal cells showed immunolocalization in both, the primary and 
 57 
secondary decidual zone.  However, cells in the secondary decidual zone, expressed 
higher intensity of VEGF localization when compared to the primary decidual zone (Fig. 
41).   
 
VEGF immunolocalization in the hyperstimulated animals at 6.5 days of pregnancy was 
evident in the cytoplasm of the luminal epithelial cells and glandular cells, while the 
stromal cells, were negative for VEGF immunolocalization (Fig. 43).  This was similar to 
the VEGF immunolocalization in the hyperstimulated animals at 4.5 and 5.5 days of 
pregnancy.   




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3.5 Summary of COX2 and VEGF immunolocalization in the control and 
hyperstimulated animals at 4.5; 5.5 and 6.5 days of pregnancy 
 
Both COX2 and VEGF were immunolocalized to the uterine tissue at the different stages 
of pregnancy examined and in both control and hyperstimulated animals.  However, 
differences, as well as similarities, in the distribution of COX2 and VEGF 
immunolocalization were evident between the two groups of animals at the various stages 
of pregnancy. 
 
COX2 was expressed in the control groups of animals at 4.5, 5.5 and 6.5 days of 
pregnancy in the luminal epithelial cells, glandular cells and in the stromal cells that 
showed decidualization.  While COX2 immunolocalization in the luminal and glandular 
epithelial cells was prominent in the control animals at 4.5 days, the intensity of 
immunolocalization decreased in these cells with the progression of pregnancy.  A high 
intensity of cytoplasmic COX2 immunolocalization was evident in the decidual stromal 
cells of the control animals at 6.5 days of pregnancy particularly in the region 
immediately adjacent to the luminal epithelial cells (primary decidual zone).  
 
In the hyperstimulated animals at 4.5 days, COX2 was present in the luminal epithelial 
cells and glandular epithelial cells and the intensity of immunolocalization increased 
slightly in these cells at 5.5 and 6.5 days of pregnancy.  The major difference in COX2 
immunolocalization between control and hyperstimulated animals was noted in the 
stromal cells. While the stroma of the control animals became decidualized and showed 
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COX2 localization in these cells at 4.5, 5.5 and 6.5 days of pregnancy, the stromal cells 
of hyperstimulated animals did not show decidua formation or localization of COX2 at 
any of the stages of pregnancy examined.  
 
VEGF, like COX2 was immunolocalized to the luminal epithelial cells, glandular cells 
and decidual stromal cells of the uterine tissue in the control animals at 4.5, 5.5 and 6.5 
days of pregnancy.  Differences in the intensity of VEGF compared to COX2 expression 
were noticed in these cells in the control animals.  The luminal epithelial and glandular 
cells showed intense VEGF immuniolocalization at all stages of pregnancy examined 
which was opposite to the COX2 immunolocalization.  Expression of COX2 decreased in 
these cells with the progression of pregnancy.  In addition, luminal epithelial cells did not 
show VEGF immunolocalization at the antimesometrial side around the implanting 
blastocyst at 6.5 days of pregnancy, while the simple cuboidal luminal epithelial cells at 
the mesometrial side expressed strong VEGF immunolocalization.  Stromal cells 
exhibited differences in immunolocalization of VEGF compared to COX2 
immunolocalization at 6.5 days of pregnancy.  While COX2 was intensely localized in 
the decidual cells immediately adjacent to the luminal epithelial cells and decreased in 
the cells distant to this area, the opposite was true for VEGF immunolocalization.  Intense 
VEGF immunolocalization was evident in the decidual stromal cells of the secondary 
decidual zone. 
 
In the hyperstimulated animals, VEGF was present in the luminal epithelial cells and 
glandular cells, but was absent in the stromal cells which remained flat at all stages of 
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pregnancy examined. This was the same for COX2 immunolocalization.  While 
cytoplasmatic COX2 immunolocalization was unevenly distributed in the cytoplasm of 
the luminal epithelial cells, VEGF was evenly expressed in these cells at all stages of 
pregnancy examined.  



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3.10 Western blot analysis for VEGF and COX2 
 
Western blot analysis was carried out on samples of extracted protein from the uterine 
tissue of the control and hyperstimulated animals at all the stages of pregnancy examined.  
 
Following electrophoresis of the samples, the gel incubated with destain 1 and destain 2 
was observed to determine the band of interest (Fig. 44).  However, it appeared that no 
band corresponding to the range of 21/42kDa (molecular weight of VEGF) or band in the 
range of 72-74kDa (molecular weight of COX2) was present.  
 
The second gel obtained after electrophoresis was used for protein transfer on to the 
nitrocellulose membrane as per materials and methods. After incubation with the primary 
and secondary antibodies the membranes were incubated with POD in order to visualize 
the bands.  However, no bands indicating VEGF or COX2 were visible on the membrane.  
Although different concentrations of the primary and secondary antibody were incubated 
with the membranes, and an increased volume of the samples was loaded for 
electrophoresis, no results could be produced.  The reason for unsuccessful Western blot 
analysis may be that the concentration of VEGF and COX2 in the sample was too low, as 
very small pieces of the uterine tissue were used for the protein extraction.  The coloured 
protein molecular weight marker used indicated that the transfer during the blotting was 
successful (Fig. 45).   
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Fig. 7: Representative photomicrograph of dissected uterine horns of a 5.5 day 
control animal. Note the presence of numerous blue bands (implantation 
sites; 13 in total). Ovaries appear normal. Pontamine blue reaction. 
 
 
 
 
 
 
Fig. 8: Representative photomicrograph of dissected uterine horns of a 5.5 day 
hyperstimulated animal. Note the dilated uterine horns and no evidence of 
blue stained implantation sites. Ovaries appear large with numerous 
follicles. Pontamine blue reaction. 
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Fig. 9:  Representative histological section of 4.5 day control ovarian tissue. 
Note numerous well developed corpora lutea (CL). Haematoxylin and 
eosin. x10. 
 
 
 
 
 
 
 
 
Fig. 10: Representative histological section of 5.5 day hyperstimulated ovarian 
tissue. Note numerous large follicles (FL) and numerous small corpora 
lutea (CL). Haematoxylin and eosin. x10. 

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Fig. 11: Representative histological section of 4.5 day control uterine tissue. 
Note the apposed uterine walls at the antimesometrial site (AMM), and the 
smooth appearance of the uterine lumen.  Decidualisation (DEC) is 
evident around the implanting embryo (EMB).  Numerous uterine glands 
(GL) are present. Haematoxylin and eosin. x10.  
 
Fig. 12: Higher magnification of 4.5 day control uterine tissue seen in Fig. 8.  Note 
the simple cuboidal luminal epithelial cells with rounded centrally placed 
nuclei (N).  The luminal epithelial cells contained vacuoles (V) basally 
placed in the cell. Immediately adjacent to the luminal epithelial cells 
around the implanting embryo (EMB), the stromal cells are rounded, 
indicating decidua formation (DEC). Haematoxylin and eosin. x40. 
 
Fig. 13.            Representative histological section of 4.5 control uterine tissue. Note the 
simple cuboidal luminal epithelial cells (LE) and glandular cells (GL) with 
vacuoles basally placed. The nucleus is centrally placed in the luminal 
epithelial cells. The apex of the luminal epithelial cells is covered with 
microvilli (MV). Subepithelial stromal cells (DEC) are rounded with 
scanty cytoplasm. Haematoxylin and eosin. x40. 
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Fig. 14: Representative histological section of 4.5 day hyperstimulated uterine 
tissue. Note the dilated uterine lumen (L) with numerous luminal mucosal 
folds. Numerous glands (GL) are present in the stroma (ST). 
Haematoxylin and eosin. x10.   
 
 
 
Fig. 15: Representative histological section of 4.5 day hyperstimulated uterine 
tissue. Note the simple columnar luminal epithelial cells (LE) with basally 
placed nuclei. The subepithelial stromal cells (ST) are flat and fibroblastic 
(open lines). Haematoxylin and eosin. x40.    
  
 
Fig. 16: Representative histological section of 4.5 day hyperstimulated uterine 
tissue showing stroma (ST) with flat, fibroblastic cells surrounding the 
uterine glands (GL).  The lumen of the glands is dilated. Glandular cells 
are simple cuboidal with nuclei basally placed in each cell. Haematoxylin 
and eosin. x40. 


 69 



 70 



Fig. 17: Representative histological section of a 5.5 day control uterine tissue.  
Note the smooth appearance of the uterine lumen (L).  Numerous glands 
(GL) are present in the endometrium.  Note that uterine stroma at the 
mesometrial uterine side (MM) appears compact, while at the 
antimesometrial side (AMM) spaces between the cells are evident 
indicating stromal oedema and formation of primary decidual zone (PDZ).  
Haematoxylin and eosin. x10.  
 
 
 
 
Fig. 18:  Representative histological section of a 5.5 day pregnant uterine tissue 
showing simple cuboidal luminal epithelial cells (LE) with numerous 
microvilli (MV) on the apical border of the cells.  Nuclei (N) are rounded 
and situated towards base of the cells.  Note scanty cytoplasm in the 
decidual stromal cells (STR) and potential spaces between these cells as a 
result of tissue oedema.  Haematoxylin and eosin. x40. 
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Fig. 19: Representative histological section of a 5.5 day hyperstimulated uterine 
tissue.  Note dilated lumen (L) and numerous luminal mucosal folds (LF). 
Haematoxylin and eosin. x10.  
 
 
 
 
 
 
 
Fig. 20:               Representative histological section of a 5.5 day hyperstimulated uterine 
tissue.  Stromal cells (STR) are fibroblastic in shape.  Uterine 
glandular cells (GL) are simple columnar with rounded basally placed 
nuclei. Haematoxylin and eosin. x40. 
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Fig. 21:  Representative histological section of a 6.5 day control uterine tissue. The 
uterine luminal mucosa appears smooth.  An embryo (EMB) is visible in 
the lumen (L). Note distinct decidua formation on the both sides of the 
lumen, mesometrial (MM) and antimesometrial (AMM) sides.  
Haematoxylin and eosin. x10. 
 
 
 
 
 
Fig. 22: Representative histological section of a 6.5 day pregnant uterine tissue at 
the antimesometrial side. Luminal epithelial cells (LE) are low simple 
cuboidal with flat to round nuclei basally placed in the cell.  Numerous 
decidual cells, rounded in shape, are visible in the subepithelial stroma 
(STR). Note numerous blood vessels (BV) surrounded by decidual cells. 
Haematoxylin and eosin. x40.   
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Fig. 23:  Representative histological section of a 6.5 day hyperstimulated uterine 
tissue.  Numerous mucosal folds (LF) are present in the dilated lumen (L).  
Note the numerous uterine glands (GL) in the stroma (STR).  
Haematoxylin and eosin. x10.  
 
 
 
 
 
 
 
Fig. 24: Representative histological section of a 6.5 day hyperstimulated uterine 
tissue.  Note simple tall columnar luminal epithelial cells (LE).  Vacuoles 
are not present in the cytoplasm of these cells.  The stromal cells (STR) 
are flat and fibroblastic.  The glandular cells (GL) are simple columnar 
with basally placed nuclei.  Haematoxylin and eosin. x40.    

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Fig. 25: Representative histological section of lung carcinoma tissue incubated 
with COX2 antibody.  Note COX2 immunolocalization in the cytoplasm 
of the tumorous cells.  Counterstained with haematoxylin. x40. 
 
 
Fig. 26: Representative histological section of 6.5 day hyperstimulated uterine 
tissue incubated with COX2 antibody, showing immunolocalization to the 
luminal epithelium (LE) Counterstained with haematoxylin. x40. 
 
 
Fig. 27a: Representative histological section adjacent to the section showing 
immunolocalization of 6.5 day hyperstimulated uterine tissue where the 
primary COX2 antibody was replaced with TRIS. Note the absence of 
immunolocalization in any compartment of the tissue. Counterstained with  
Haematoxylin. x40. 
 
Fig. 27b: Representative histological section adjacent to the section showing 
immunolocalization of 6.5 day hyperstimulated uterine tissue where the 
secondary antibody was replaced with TRIS. Note the absence of 
immunolocalization in any compartment of the tissue. Counterstained with  
Haematoxylin. x40. 
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Fig. 28: Representative histological section of a 4.5 day control uterine tissue.  
Note immunolocalisation of COX2 in the luminal epithelial cells (LE).  
Note scanty localization of COX2 in the cytoplasm of the subepithelial 
stromal cells (straight lines).  Counterstained with haematoxylin. x40. 
 
 
 
 
 
Fig. 29: Representative histological section of a 4.5 day hyperstimulated uterine 
tissue.  Note the strong but variable immunolocalization of COX2 in the 
luminal epithelial cells (LE).  In the glandular cells (GL) scanty 
immunolocalization is evenly distributed.  No localization of the antibody 
was observed in the subepithelial stromal cells.  Counterstained with 
haematoxylin. x40. 

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Fig. 30: Representative histological section of a 5.5 day control uterine tissue. 
Immunolocalisation of COX2 in the luminal epithelial cells (LE) and 
glandular cells (GL) is present, but weak.  Note irregular COX2 
immunolocalization in the subepithelial stromal cells (STR).Cells 
immediately adjacent to the luminal epithelial cells show intense 
immunolocalization (straight lines), compared to the cells distant to the 
luminal epithelial cells. Counterstained with haematoxylin. x40. 
 
 
 
Fig. 31: Representative histological section of a 5.5 day hyperstimulated uterine 
tissue.  Note intense but irregular immunolocalization of COX2, 
predominantly distributed around the nucleus of the luminal epithelial 
cells (LE).  Immunolocalization is evident in the glandular cells, while no 
localization of the antibody is observed in the subepithelial stromal cells 
(STR). Counterstained with haematoxylin. x40. 
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Fig. 32: Representative histological section of the uterus of a 6.5 day control 
animal. Note that localisation of COX2 was not evident in the cytoplasm 
of the luminal epithelial cells (LE) at the side of the implanting embryo.  
The subepithelial stromal cells (STR) in the primary decidual zone showed 
intense localization of COX2, while stromal cells in the secondary 
decidual zone distant to the lumen expressed low intensity of COX2 
localization. Scanty COX2 immunolocalization was evident in the 
peripheral cells of embryo (EMB). Counterstained with haematoxylin. 
x40. 
 
 
 
 
Fig. 33: Representative histological section of the uterus of a 6.5 day 
hyperstimulated animal. Note intense, but irregular, immunolocalization of 
COX2 in the luminal epithelial cells (LE).   No localization of COX2 is 
observed in the subepithelial stromal cells (STR).  Counterstained with 
haematoxylin. x40. 
 

 85 




 86 
Fig. 34: Representative histological section of breast carcinoma tissue. Note 
immunolocalization of VEGF in the cytoplasm of the tumour cells (TC). 
Counterstained with haematoxylin. x40. 
 
 
Fig. 35: Representative histological section of 6.5 day pregnant uterine tissue 
showing VEGF immunolocalization in the cytoplasm of the stromal cells 
(STR), no immunolocalization was evident in the luminal epithelial cells 
(LE). Counterstained with haematoxylin. x40.  
 
Fig. 36a: Representative histological section of the uterus of a 6.5 day control 
animal adjacent to section in Fig. 32, where the primary VEGF antibody 
was replaced with TRIS.  Note that the luminal epithelial cells and stromal 
cells are not expressing cytoplasmatic VEGF immunolocalization. 
Counterstained with haematoxylin. x40. 

Fig. 36b: Representative histological section of 6.5 day pregnant uterine tissue 
adjacent to the section in Fig. 32, where the secondary antibody was 
replaced with TRIS.  Note that the no immunolocalization was evident in 
any tissue compartment. Counterstained with haematoxylin. x40. 
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Fig. 37: Representative histological section of the uterus of a 4.5 day control 
animal.  Note the immunolocalisation of VEGF in the luminal epithelial 
(LE) cells and glandular cells (GL).  Localization of the antibody is also 
evident in the subepithelial stromal cells (STR). Counterstained with 
haematoxylin. x40. 
 
 
 
 
Fig. 38: Representative histological section of the uterus of a 4.5 day 
hyperstimulated animal.  Note the immunolocalization of VEGF in the 
luminal epithelial cells (LE) and the glandular cells (GL), particularly in 
the apical portion of these cells (straight lines).  No localization of the 
antibody is observed in the subepithelial stromal cells (STR).  
Counterstained with haematoxylin. x40. 
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Fig. 39: Representative histological section of the uterus of a 5.5 day control 
animal.  Immunolocalisation of VEGF is present in the luminal epithelial 
cells (LE) and the glandular cells (GL). Note the high intensity of 
cytoplasmic VEGF localization in the subepithelial stromal cells (STR). 
Counterstained with haematoxylin. x40. 
 
 
 
 
Fig. 40: Representative histological section of the uterus of a 5.5 day 
hyperstimulated animal. Note immunolocalization of VEGF in the luminal 
epithelial cells (LE) and glandular cells (GL), predominantly in the apical 
portions (straight lines). No localization of VEGF is observed in the 
subepithelial stromal cells (STR). Counterstained with haematoxylin. x40. 
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Fig. 41: Representative histological section of the uterus of a 6.5 day pregnant 
animal.  An embryo (EMB) is visible in the lumen at the antimesometrial 
side (AMM).  Stromal cells immediately adjacent to the luminal epithelial 
cells (primary decidual zone PDZ) show less VEGF immunolocalization 
compared to the stromal cells in the secondary decidual zone (SDZ). 
Counterstained with haematoxylin. x10. 
 
    
 
 
Fig. 42: Representative histological section of the uterus of a 6.5 day control 
animal. Luminal epithelial cells (LE) do not show VEGF localization.  
Note scanty cytoplasmatic localization in the decidual cells (DEC) 
immediately adjacent to the implanting embryo (E).  Embryonic cells 
show high intensity of VEGF immunolocalization.  Counterstained with 
haematoxylin. x40. 

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Fig. 43:  Representative histological section of the uterus of a 6.5 day 
hyperstimulated animal.  Note numerous folds, lined with the simple 
columnar epithelium, showing apical VEGF cytoplasmic 
immunolocalization (straight lines).  The immunolocalization is also 
evident in the glandular cells.  Stromal cells are flat and fibroblastic and 
do not show VEGF immunolocalization.  Counterstained with 
haematoxylin. x40. 
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Fig. 44: Representative gel after protein separation stained with Commasie 
stain in the different groups of animals.  Lane A was loaded with 
molecular weight marker (Sigma-Aldrich Co., USA), B= protein extract 
sample of 6.5 day control rat, C = 6.5 day hyperstimulated rat, D = 5.5 
control rat, in E =5.5 day hyperstimulated rat, F = 4.5 day control rat and 
G = 4.5 day hyperstimulated rat. 
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 Fig. 45: Nitrocellulose membrane after Western blotting, representing 
expression of VEGF protein in the rat uterus.  The molecular weight 
marker confirmed successful transfer from the gel to the membrane.  
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4.0 DISCUSSION       
 
The ovarian steroids oestrogen and progesterone are crucial in regulating uterine 
receptivity (Psychoyos, 1973; Carson, 2000; Day et al., 2004).  Numerous studies in 
normal pregnant rodents have shown that preparation of the endometrium during the pre-
implantation stage is influenced by progesterone, while blastocyst implantation is 
initiated by oestrogen (Ljungkvist, 1972; Psychoyos, 1973).  However, the low 
implantation rates in controlled ovarian stimulation [used in in vitro fertilization (IVF) 
and embryo transfer (ET) techniques] are the result of disruption of the synchrony of the 
hormonal milieu and cause detrimental changes to the uterine morphology.  This affects 
uterine receptivity (Gidley-Baird et al., 1986; Kramer et al., 1990; Stein et al., 1993; 
Simon et al., 1995, 1998; Bourgain and Devroey, 2003) and expression of implantation 
related genes (Ma et al., 2003).  
 
4.1 Gross morphological changes in the uterus caused by exogenous hormones 
In the present study, superovulation (hyperstimulation) of animals was achieved by 
administration of exogenous hormones (FSH and hCG), following the work of Kramer et 
al. (1990) and Stein et al. (1993).  This resulted in the ovaries becoming cystic and 
enlarged.  Exogenous hormones also affected the gross morphological appearance of the 
uterine horns which appeared markedly dilated in the hyperstimulated animals at 4.5, 5.5 
and 6.5 days compared to the control animals.  This was in accordance with previous 
studies by Stein and Kramer (1989) and Kramer et al. (1990). 
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Intravenous injection of a macromolecular blue dye, pontamine blue, results in the 
appearance of blue bands at the site of the implanting embryos (Psychoyos, 1973). 
Control animals showed numerous blue bands along the uterine horns at 5.5 and 6.5 days 
of pregnancy, while in the hyperstimulated animals, blue bands were not observed, 
indicating failure of vascular permeability and embryo implantation in these animals. 
  
4.2. Oestradiol and progesterone concentrations and the P:E2 ratio in the control 
and hyperstimulated animals during the peri-implantation period 
In the present study, the oestradiol concentrations increased with the progression of 
pregnancy in the control animals while, in the hyperstimulated animals an initial rise of 
oestradiol concentrations from 4.5 days to 5.5 days was followed by a marked decrease at 
6.5 days. 
  
Although the oestradiol concentration was higher in the hyperstimulated compared to the 
control animals at 4.5 days of pregnancy, this was not statistically significant.  This was 
not in agreement with the findings of Kramer et al. (1990), where a statistically higher 
oestradiol concentration was found in the hyperstimulated animals compared to control 
animals at 4.5 days of pregnancy.  While the type of animals and protocols were identical 
in the study by Kramer et al. (1990) and the present study, the differences in these two 
observations may be due to the different kits used to assess oestradiol concentration.  In 
the present study, an oestradiol ELISA kit was used, while in the study by Kramer et al. 
(1990) a RIA kit was used to measure oestradiol concentrations.  In addition, although in 
both studies the blood samples were obtained from the animals in the morning, slight 
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difference in timing of obtaining the samples may cause different outcomes.  This is due 
to the variations in timing of implantation that can differ between animals by half a day 
(Enders, 1975), as well as rapid fluctuations in the hormonal levels during the short peri-
implantation period. 
  
The oestradiol concentrations were higher in both the control and hyperstimulated 
animals at 5.5 days of pregnancy when compared to that at 4.5 days.  In addition, the 
hyperstimulated animals had higher oestradiol concentrations at 5.5 days compared to the 
animals in the control group on the same day of pregnancy.  However, once again, this 
was not statistically significant.  A similar finding was previously reported by Kramer et 
al. (1990), where no statistically significant differences were found in the 
hyperstimulated compared to the control animals on day 5.5 of pregnancy, although 
higher oestradiol levels were evident in the hyperstimulated animals.  The similarity in 
the results between the present and the previous study by Kramer et al. (1990) may be 
due to a better correlation in the timing of sample collections from these animals.   
  
Statistically significantly lower oestradiol concentrations in the hyperstimulated animals 
compared to the control animals at 6.5 days were the result of a marked decrease in the 
oestradiol concentration in the hyperstimulated animals.  In the study by Kramer et al. 
(1990) no statistically significant differences were noted in the hyperstimulated animals 
at 6.5 days.  This does not correspond with the present study. However, again it is 
possible that some of the animals, due to a difference in timing of sample collection were 
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in a more advanced phase of pregnancy compared to the animals in the previous study, 
causing discrepancies in the results between the two studies. 
  
In the control animals, the rise of progesterone concentrations from 4.5 days to 5.5 days 
of pregnancy, and a slight decrease at 6.5 days of pregnancy was noted.  However, in the 
hyperstimulated animals, the progesterone concentrations increased with the progression 
of pregnancy.  Statistically significantly higher progesterone concentrations were found 
in the hyperstimulated animals when compared with the control animals at 6.5 days of 
pregnancy.  In a previous study by Kramer et al. (1990), progesterone concentrations 
were measured in the control and hyperstimulated animals from 1.5 to 6.5 days of 
pregnancy. However, no statistically significant differences in progesterone levels were 
found at any stage of pregnancy between the control and hyperstimulated animals.  
Differences in the outcome of the progesterone concentrations in the present study and 
the previous study by Kramer et al. (1990) may be due to the different kits used in these 
two studies. 
 
It is well established that steroidal hormones, oestrogen and progesterone do not act 
independently in mediating events in the preparation of the uterus for the blastocyst 
implantation and establishment of pregnancy (Psychoyos, 1973; Gidley-Beard et al., 
1986; Tan et al., 1999).  Gidley-Beard et al. (1986) proposed that assessing the 
progesterone:oestradiol ratio (P:E2) could be considered as a better predictor for the 
success of implantation than assessment of the levels of either hormone.  Studies in 
women attending infertility clinics showed that a higher P:E2 ratio and lower oestradiol 
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levels were a common appearance in women that became pregnant to those that failed to 
became pregnant after treatment with the exogenous hormones (Gidley-Beard et al., 
1986).  Kramer et al. (1990) reported a similar finding in the study on the rats treated 
with exogenous hormones. The lower P:E2 ratio and higher oestradiol concentrations 
during the peri-implantation stages of these animals coincided with the suppression of 
implantation.  The control animals however, had higher P:E2 ratio and lower oestradiol 
concentrations which was accompanied by implantation of numerous blastocysts.  The 
present study is in support of observations by Gidley-Beard et al. (1986) and Kramer et 
al. (1990).  The control animals had higher P:E2 ratio and lower oestradiol levels at the 
time of blastocyst apposition, attachment and initiation of implantation at days 4.5 and 
5.5 of pregnancy when compared to the hyperstimulated animals at the same stages of 
pregnancy.  Numerous implantation sites were evident in the control animals at 5.5 and 
6.5 days of pregnancy, while no implantation sites were evident in the hyperstimulated 
animals. At 6.5 days of pregnancy, the hyperstimulated animals had a higher P:E2 ratio 
and lower oestradiol concentrations when compared to the control animals at 6.5 days of 
pregnancy. However, implantation sites were observed only in the control animals. 
  
4.3. Uterine receptivity and embryo implantation in the control and hyperstimulated 
animals 
The specific, transient, but unique period of uterine receptivity known as the “window” 
of implantation is a limited period of time which determines the uterine readiness to 
accept the blastocyst (Psychoyos, 1973; Day, 1996; Ma et al., 2003).  Ma et al. (2003) 
reported that oestrogen at different physiological concentrations can initiate implantation 
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while, the higher oestrogen concentrations affect the duration of the window of 
implantation, causing its rapid closure.  The window of implantation is also characterized 
by the morphological features of the receptive uterus, necessary for successful 
implantation (Enders and Schlafke, 1967; Psychoyos, 1973; Enders, 1975; Kramer et al., 
1990). 
   
In the present study at 4.5 days of pregnancy in the control rats, blastocysts were found at 
the antimesometrial side of the smooth uterine lumen.  The luminal fluid was reduced 
indicated by the luminal walls appearing to be in apposition, closing down around the 
blastocyst. Reduction of the uterine luminal fluid is associated with uterine receptivity in 
the rat and dependant on the presence of a blastocyst and appropriate hormonal 
environment (Lindsay and Murphy, 2006.).  Also in the human uterus, embryo 
attachment is accompanied by the extraction of uterine luminal fluid (Edwards, 1995).  
These morphological changes in the uterine tissue of the control animals allow 
trophoblastic cells of the implanting blastocyst to be in close contact with the luminal 
epithelial cells (Enders and Schlafke, 1967).  In the hyperstimulated animals at 4.5 days, 
the uterine lumen was highly folded and dilated. Luminal dilation in these animals 
indicated the presence of excessive fluid.  High oestradiol and progesterone levels in 
these animals appear to be the cause of aberrant redistribution of aquaporins (specialized 
transporters for the fluid in the transcellular fluid transport across cells) causing fluid 
retention in the uterine lumina of the hyperstimulated animals (Lindsay and Murphy, 
2006). 
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Since the luminal epithelial cells are the site of the attachment of the blastocyst with the 
uterus, transition of the surface epithelium from the non-receptive to receptive state 
occurs as remodeling of these cells under the influence of the ovarian hormones 
(Psychoyos, 1973). The hormonal regulation is mediated through nuclear receptors, the 
oestrogen receptors  and ß (ER-  and ER- ß) and the progesterone receptor (PR) which 
exists in two isoforms (Tan et al., 1999). Tan et al. (1999) reported proliferation of the 
luminal epithelial cells under the influence of pre-ovulatory oestrogen which coincides 
with the expression of the oestrogen receptor  (ER-) in these cells on day 1 and 2 of 
pregnancy. A decrease in proliferation and occurrence of differentiation of the luminal 
epithelial cells, correlated with the expression of ER- and PR (Tan et al., 1999). 
Differentiation of these cells is essential for implantation and occurs on day 4 of 
pregnancy in mice under the influence of progesterone and a nidatory surge of oestrogen 
(Tan et al., 1999).  
  
In the present study, the simple cuboidal luminal epithelial cells of the control animals at 
4.5 days of pregnancy showed morphological features of the receptive epithelium. The 
luminal epithelial cells contained large, basally placed lipid vacuoles, and their apical 
portions were covered with short microvilli. These findings were consistent with findings 
by Enders and Schlafke (1967).  Also, Psychoyos and Martel (1985) reported flattening 
of the microvilli of the luminal epithelial cells around the receptive phase in the normal 
rat uterus.  In contrast, in the hyperstimulated animals the luminal epithelial cells were 
high columnar and did not contain vacuoles, while microvilli were numerous and 
appeared longer compared to that of the control animals.  With the progression of 
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pregnancy in the rat uterus, other specializations of the apical portions of the luminal 
epithelial cells emerge.  Ljungkvist (1972) reported flattening of the microvilli and 
appearance of cytoplasmic projections or “pinopodes” in the rodent uterus. Similar 
structures are evident in the human uterus by day 18-19 of the menstrual cycle and are 
present for 24-48 hours (Psychoyos and Martel, 1985). The pinopodes or uterodomes in 
the human uterus are believed to be involved in the reduction of the luminal fluid 
(Psychoyos and Martel, 1985). The pinopodes are also considered as specific markers of 
uterine receptivity (Bagot et al., 2001). 
 
The morphological features of the luminal epithelium of the hyperstimulated animals 
coincided with the increased oestradiol levels in these animals when compared to the 
control animals at the same stage of pregnancy.  A previous study by Ljunkvist (1972) 
showed that the microvilli of the luminal epithelial cells increased in length after 
oestrogen treatment of ovariectomized mice.  Williams and Rogers (1980) demonstrated 
marked reduction in the cytoplasmic lipid droplets in the ovariectomized rat after 
treatment with oestrogen.  Kramer et al. (1990) and Stein et al. (1993) reported 
significantly higher epithelium in the hyperstimulated animals at 4.5 days, when higher 
oestrogen and progesterone levels were recorded.  The findings in the present study are 
consistent with these studies, were, in the hyperstimulated animals, higher oestradiol 
levels where associated with tall columnar luminal epithelial cells.  Cytoplasmic lipid 
vacuoles were absent from these cells.  Therefore the nuclei were not displaced and were 
basally placed. 
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The stroma of the 4.5 day control animals was compact, except at the antimesometrial 
side where a number of cells were rounded and widely separated, indicating tissue 
oedema.  Enders and Schlafke (1967) previously reported similar results, indicating that 
the subepithelial stroma remains compact in the rat uterus on a day 5 (4.5).  
 
In contrast, the subepithelial stroma of the hyperstimulated animals at day 4.5 remained 
compact, with flat, fibroblastic cells.  Thus, the stroma did not show signs of 
decidualization.  It has been suggested that failure of the stromal cells to decidualise 
following hyperstimulation is due to the increased levels of oestradiol caused by 
administration of the exogenous hormones, FSH and hCG (Stein and Kramer, 1987; 
Fossum et al., 1989; Kramer et al., 1990; Kramer, 1997). Numerous studies of the human 
endometrium suggest unfavorable, detrimental endometrial changes resulting in low 
implantation rates under the influence of the exogenous hormones used in assisted 
reproductive procedures (Testart, 1987; Sterzik et al., 1988; Fossum et al., 1989; Paulson 
et al., 1990). 
 
At the electron microscopic level in the control rats, well defined fenestrations in, and 
gaps between, endothelial cells in the uterine thin-walled blood vessels are present in the 
control animals at 4.5 and 6.5 days of pregnancy, allowing vascular leakage at the site of 
implantation (Kramer et al., 1993; Kramer, 1997). These are not present in the blood 
vessels of hyperstimulated animals at the same stages of pregnancy (Kramer et al., 1993; 
Kramer, 1997).  The vascular permeability at the site of implantation can be 
demonstrated by the injection of the pontamine blue dye, resulting in the formation of the 
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blue bands along the uterine horns at the site of the implanting blastocyst (Psychoyos, 
1973). However, blue bands were not observed in the hyperstimulated and control 
animals at 4.5 days, except in one control animal where three blue bands were found.  
The animals were killed on the morning of day 4.5 of pregnancy which is prior to the 
time given for normal implantation (Enders and Schlafke, 1967; Psychoyos, 1973), and 
the pontamine blue reaction is not usually found at that time (Enders and Schlafke, 1967).  
However, the presence of blue bands in an animal at 4.5 days is a possible occurrence, as 
variation may occur in the time of implantation in different animals (Enders, 1975). 
  
Changes in the uterine morphology under the synchronized release of steroid hormones in 
the control animals were favorable for blastocyst implantation which resulted in 
numerous implantation sites in the 5.5 day control animals.  This was confirmed by 
numerous blue stained bands along the uterine horns of the control animals.  Routine 
histology of the uterine tissue of the 5.5 day control animals showed flattening of the 
luminal epithelial cells at the antimesometrial side of the lumen, together with 
disappearance of vacuoles in these cells. The nuclei of these cells were irregular in shape. 
These findings are consistent with the previous findings of Psychoyos (1973) and Parr et 
al. (1987).  The microvilli of the luminal epithelial cells at the site of blastocyst 
implantation were flattened, compared to the microvilli of these cells at the mesometrial 
side (Enders, 1975; Parr et al., 1987).  On the contrary, the histological appearance of the 
luminal epithelial cells of the hyperstimulated animals at 5.5 day appeared unchanged 
when compared to that at 4.5 days.  
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The subepithelial stromal cells around the implanting blastocyst in the control animals at 
day 5.5 of pregnancy were rounded with large nuclei indicating formation of a distinct 
decidual zone. The proliferation of the subepithelial stromal cells was previously defined 
as the primary decidual zone by Day (1996).  The stroma of these animals was also 
highly vascularized and oedematous.  However, in the hyperstimulated animals 
decidualization did not occur and the cells appeared compact as has been previously 
reported (Stein and Kramer, 1987; Kramer et al., 1990; Kramer, 1997).  Observations of 
the uterine horns did not show blue stained bands after the pontamine blue injection. This 
indicated the failure of implantation. However, one blue band in each of two 
hyperstimulated animals at 5.5 days demonstrated possible sites of blastocyst 
implantation in these animals.   
 
At this stage of pregnancy in the hyperstimulated animals, higher oestradiol and 
progesterone concentrations were measured compared to that at 4.5 days of 
hyperstimulation.  It has been previously reported that high progesterone levels alone are 
not inhibitory to implantation.  Progesterone can act against the inhibitory effect of high 
oestradiol levels (Gidley-Baird, 1986).  A recent study on the uterus of pseudopregnant 
mice showed that progesterone supplementation can extend the uterine receptivity 
through day 6 (Song et al., 2007). However, in the present study, the rise of oestradiol 
levels together with the rise of progesterone, coincided with the lower P:E2 ratio when 
compared to the control animals at 5.5 days.  This concurs with the study by Gidley-
Baird (1986) who stated that the P:E2 ratio is a better predictor of the success of the 
implantation. It has also been shown by Fossum et al. (1989), that after embryo transfer 
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in mice treated with an intraperitoneal injection of pregnant mare’s serum gonadotropin 
and hCG, the implantation rate decreased.  The implantation rate was statistically 
significantly lower in the hyperstimulated mice (8%) compared with 50% in the control 
mice. 
  
In addition, it appears that the high oestradiol levels at 4.5 days hyperstimulated animals 
may have caused the premature closing of the “window” of implantation.  This may have 
caused the premature transition of the uterus to a refractory state.  Indeed, in the present 
study the persistent morphology of the uterus in the hyperstimulated animals at 4.5 and 
5.5 days of pregnancy showed the features of an unsatisfactory uterine morphology for 
blastocyst implantation.  
 
In the control animals at 6.5 days of pregnancy, the luminal epithelial cells showed signs 
of detachment and disappearance at the site of the implanting blastocyst, allowing the 
trophoblast to invade the stroma.  An ultrastructural study of the luminal epithelial cells 
of mouse and rat embryo implantation sites shows features of apoptosis, rather than of 
necrosis, of these cells (Parr et al., 1987). The embryos were commonly observed in the 
elongated implantation region at the antimesometrial side of 6.5 days control rats with the 
embryonic cell mass facing the mesometrial side of the lumen. Implantation of embryos 
was followed by extensive stromal decidualization and formation of a secondary decidual 
zone. Day (1996) defined the secondary decidual zone as a zone of stromal cells 
proliferation outside the primary decidual zone.  
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In the hyperstimulated animals at 6.5 days, the histology of the uterus did not show any 
changes compared to the hyperstimulated animals at the previous stages of pregnancy.  
However, the hormonal milieu at 6.5 days hyperstimulated animals appeared to be 
favorable for blastocyst implantation. The oestradiol concentrations dropped significantly 
while progesterone levels increased when compared to the control animals at the same 
stage of pregnancy.  Even so, the P:E2 ratio was higher when compared to the previous 
stages in the hyperstimulated animals and statistically significantly higher when 
compared to the control animals at 6.5 days. The pontamine blue reaction was not evident 
in these animals, and the histology of the uterus showed no signs of stromal oedema or 
decidua formation, indicating failure of fenestration of blood vessels and lack of tissue 
oedema.  
 
In addition, it has been previously shown that although hyperstimulated animals have 
typical pregnancy vaginal smears, these animals do not have successful pregnancies and 
revert to the oestrous cycle after 10 days (Kramer et al., 1990).  It is also known that the 
closing of the window of implantation is followed by the refractory stage, when the 
uterus is unable to accept the blastocyst.  The refractory phase is under the influence of 
the same hormones (oestrogen and progesterone) which are also responsible for the 
preparation and initiation of pregnancy (Psychoyos, 1973).   
 
The other reason for implantation failure in the hyperstimulated animals might be the 
negative effect of raised steroid hormones on the development of the embryos.  Previous 
findings by Stein and Kramer (1989), Kramer et al. (1990) and Kramer (1997) also 
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showed that although hyperstimulated animals did not have blue bands following 
pontamine blue injection, embryos were present in the lumina of the uterine horns. 
However, embryos seen in tissue sections of these animals were undeveloped and 
unattached to the luminal epithelium.  Thus, it was possible to flush these unattached 
embryos out of the uterine horns at 5.5 and 6.5 days of pregnancy (Kramer, 1997).  In a 
study by Ertzeid and Storeng (2001), a significantly lower implantation rate was noted 
when blastocysts from the hyperstimulated donors were transferred into the control 
recipient, compared to the transfer of the blastocyst from the control donors.  
   
4.4. COX2 and VEGF expression in the control and hyperstimulated rat uterus 
Studies in rodents using either pseudopregnant or knockout animal models have revealed 
the importance of VEGF and prostaglandins, produced by the COX pathway, in early 
pregnancy and their effect on vascular permeability and angiogenesis (Kennedy, 1977; 
Kennedy and Lukash, 1982; Lim et al., 1997; Matsumoto et al., 2002; Chakraborty et al., 
1995; Bates and Harper, 2003).  However, inhibition of decidualization and vascular 
permeability under the influence of exogenous hormones, previously reported by Kramer 
et al. (1993) and Kramer (1997) were suggested to be the result of increased levels of 
oestradiol and progesterone during the peri-implantation in rats.  In the present study, it 
appears that expression and distribution of VEGF and COX2 during the peri-implantation 
period were also affected in the hyperstimulated animals after the administration of 
exogenous hormones.  
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4.4.1. COX2 Immunolocalization in the control and hyperstimulated rat uterus 
In the present study, marked differences were evident in COX2 expression in the rat 
uterus between the control animals at consecutive stages of pregnancy, indicating 
involvement of COX2 in the regulation of numerous events during the peri-implantation 
period.  However, COX2 immunolocalization did not change substantially in the 
hyperstimulated animals at consecutive stages of pregnancy and appeared to be severely 
affected by the administration of the exogenous hormones (FSH and hCG) when 
compared to the control animals.  Western blot analysis did not show any results.  After 
electrophoresis of the protein the band corresponding to the molecular weight marker at 
80kD which is the molecular weight of COX2 could not be determined.  A reason for this 
could be that the COX2 protein concentration in the sample was too low to be detected.  
 
Studies in the rodent uterus have shown that prostaglandins produced from arachidonic 
acid through the COX pathway are implicated in the process of vascular permeability, 
angiogenesis, as well as adhesion and blastocyst invasion of the stroma during the peri-
implantation period (Chakraborty et al., 1996; Lim et al., 1997; Matsumoto et. al., 2002).  
Two COX isoforms are differently expressed during the peri-implantation period in 
rodents.  At the site of implantation, COX1 expression is more constant and occurs in the 
rodent uterus prior to implantation.  COX2, on the contrary, is up-regulated during 
inflammation and cellular transformation by various stimuli (Hla and Neilson, 1992, 
Smith et al., 1994).  The expression of COX2 is suggested to be one of the crucial factors 
during the peri-implantation period in the rodent uterus (Lim et al., 1997; Matsumoto et 
al., 2002).   
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In the present study, it appears that the presence of numerous implantation sites during 
the peri-implantation period of the control rats was the result of the synchronized steroid 
hormonal release.  The routine histology of the normal pregnant uterus showed features 
of the receptive uterus, while immunohistochemistry showed distribution of COX2, both 
in the luminal epithelial cells and stroma.  In contrast, hyperstimulated rats had higher 
progesterone and oestradiol concentrations compared to the control animals during peri-
implantation period, morphological features of a non-receptive surface epithelium and 
intense COX2 immunolocalization in the luminal epithelial cells, but not in the stroma.  
 
 It is well established that during early pregnancy the attachment reaction is followed by 
apoptosis of the luminal epithelial cells (Parr et al., 1987; Tsujii and Du Bois, 1995; 
Carson et al., 2000; Tassell et al., 2000; Zhang and Paria, 2006).  At the same time, 
extensive proliferation and differentiation of the stromal cells occurs to form the decidua 
(Enders and Schlafke, 1967; Kramer et al., 1990; Kramer, 1997; Carson et al., 2000).  In 
the present study, only light microscopy was used to study the morphology of the uterus. 
Thus, apoptotic luminal epithelial cells could not be identified.  However, the flattening 
and detachment of luminal epithelial cells noticed in the control animals at 6.5 days of 
pregnancy, was not evident in the hyperstimulated rats.  A previous study by Tsujii and 
Du Bois (1995) on intestinal epithelial cells, suggests that COX2 over-expression 
suppresses apoptosis and causes changes in cellular adhesion.  The intense COX2 
expression in the luminal epithelial cells of the hyperstimulated animals may be 
considered as over-expression.  Over-expression of COX2 may thus have contributed to 
the unsuccessful implantation of embryos in the hyperstimulated animals.  The presence 
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of unattached embryos in the uterine lumen of hyperstimulated animals, as has been 
observed in the present study and previous studies by Stein and Kramer (1989), Kramer 
et al. (1990) and Kramer (1997), may be influenced by the over-expression of COX2.   
Different uterine cells are organized in tissue compartments which are involved in 
signaling from one compartment to another and are regulated by the steroid hormones, 
oestrogen and progesterone.  It has been previously reported that signaling from the 
luminal epithelial cells is required to induce the decidual reaction in the stroma (Lejeune, 
1981).  Lim et al. (1997) reported that expression of COX2 mRNA in the luminal 
epithelial cells of the mouse uterus is important in initiating decidualization.  Thus, in the 
present study, COX2 expression in the luminal epithelial cells of the control animals was 
indeed followed by initiation of stromal decidualization, seen as rounding of the 
subepithelial stromal cells.  Decidualization however, was not observed in the stroma of 
the hyperstimulated animals, although intense COX2 immunolocalization in the luminal 
epithelial cells was evident during the peri-implantation.  It appears that over-expression 
of COX2 may also be inhibitory to stromal decidualization.  
  
Early studies on the rodent uterus suggested an important role for prostaglandins in the 
initiation of decidualization at the site of implantation (Kennedy, 1977; Kennedy and 
Lukash, 1982).  It has been previously reported that treatment with indomethacin (an 
inhibitor of prostaglandin biosynthesis) at the time of implantation, can cause a delay in 
implantation (Kennedy, 1977).  In the same study, it was noted that the concentrations of 
prostaglandins were significantly higher in the implantation sites of control, compared to 
implantation sites of the indomethacin-treated animals at day 5 of pregnancy (Kennedy, 
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1977).  Later, Kennedy and Lukash (1982) showed that after the initial decidualization, 
prostaglandin levels decreased, indicating that decidual growth did not require high 
prostaglandin levels.  Studies on COX2 knock-out mice showed that artificial 
decidualization does not occur after intraluminal oil infusion on day 4 of 
pseudopregnancy, even if the physiological steroidal regime is provided (Lim et. al., 
1997).  This suggests that COX2 may be one of the crucial mediators for blastocyst 
implantation.   
 
Decidualization failure in the hyperstimulated animals coincided with the rise of 
oestradiol and progesterone at 5.5 days of pregnancy, the lower P:E2 ratio compared with 
the control animals and the absence of COX2 immunolocalization in the stromal cells.  
Previously, Hewitt et al. (2002) showed that initial COX2 induction is hormone 
independent, while its later induction is dependant on both progesterone and oestrogen 
priming.  Chakraborty at al. (1996) stated that COX1 gene expression is influenced by 
ovarian hormones, while the COX2 gene expression is hormone independent and 
regulated by the implanting blastocyst.  However, in the present study it appears that 
higher concentrations of oestradiol and progesterone inhibited stromal COX2 expression 
thus the stroma did not show signs of decidualization in the hyperstimulated animals.  Ma 
et al. (2003) indeed showed aberrant expression of the COX2 gene at higher oestrogen 
levels in pseudo-pregnant mice.  Injection of a high dose of oestrogen on day 7 
immediately after blastocyst transfer did not change the normal expression of the COX2 
gene within a 24 h period.  However, the COX2 gene could not be detected after 24 hours 
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of injection of the high oestrogen dose, and aberrant expression of other implantation-
related genes were also noted (Ma et al., 2003).  
The regulation of COX2 expression is also regulated by the presence of the blastocyst in 
the uterine lumen (Chakraborty at al., 1996).   However, although embryos were 
observed in hyperstimulated animals in the present and previous studies, the embryos 
were not attached to the surface epithelium and the stroma did not show decidualization 
and COX2 immunolocalization.  Thus, it can be concluded that not only the presence of 
the blastocysts in the uterine lumen, but attachment to the surface epithelium is required 
for the regulation of COX2 expression and initiation of decidualization of the stroma. 
   
Intense COX2 immunolocalization was also observed in the luminal epithelial cells of the 
hyperstimulated animals at 6.5 days. However, the higher P:E2 ratio of these animals and 
statistically significantly lower oestradiol concentration when compared to the control 
animals at the same stage of pregnancy, did not allow for the induction of  
decidualization and COX2 immunolocalization in the stromal cells.  Thus, it appears that 
not only expression, but rather optimal expression of COX2 in the luminal epithelial cells 
is required to induce decidualization of the stroma.  It is also possible that the refractory 
state of the uterus induced at the earlier stages of pregnancy at 4.5 and 5.5 days at higher 
oestradiol and progesterone concentrations, was not converted to the receptive state with 
the improved hormonal environment in the hyperstimulated animals at day 6.5. 
  
Kennedy and Lukash (1982) reported an increase in vascular permeability in the rat 
uterus in response to prostaglandin infusion.  In the present study, blue stained bands as a 
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result of vascular permeability were present along the uterine horns of the control animals 
at 5.5 and 6.5 days of pregnancy.  In addition, routine histology of the uterine sections of 
the control animals at the same days of pregnancy showed spaces between decidual cells 
indicating stromal oedema.  COX2 was immunolocalized in the cytoplasm of these 
decidual cells, at the antimesometrial side, indicating an influence of COX2 on vascular 
permeability and tissue oedema at the site of implantation.  Chakraborty et al. (1996) 
reported COX2 gene expression in the luminal epithelium and subepithelial stroma at the 
antimesometrial side of the mouse uterus on day 4 and day 5 of pregnancy. Chakraborty 
et al. (1996) suggested that the mesometrial COX2 gene expression on day 6 of 
pregnancy facilitated the establishement of the placenta.  Intense cytoplasmic COX2 
immunolocalization in the subepithelial stromal cells adjacent to the implanting embryo 
at day 6.5 in the present study differs from the study by Chakraborty et al. (1996).  In the 
present study the rat uterus was used while Chakraborty et al. (1996) used mouse uterus 
for their experiment, which could be the reason for the discrepancies in the observations 
between the two studies.  
 
Evidence that prostaglandins are important inducers of vascular permeability has been 
confirmed in studies on mutant mice.  Matsumoto et al. (2002) reported poor vascular 
permeability at the site of blastocyst apposition in COX2 deficient mice, proposing that 
fenestration of the uterine vessels had not occurred.  In the present study in control rats 
numerous blood vessels were observed in the stroma, surrounded by the decidual cells, 
particularly at 5.5 and 6.5 days of pregnancy.  In contrast, the non-decidualized and 
compact stroma of the hyperstimulated animals did not show a rich blood supply.   
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Numerous studies on mutant mice have shown a crucial role for COX2 during the peri-
implantation period.  COX2 deficient mice show multiple reproductive failures, causing 
infertility of these animals (Lim et al., 1997).  However, recent study by Cheng and 
Stewart (2003) argued these statements by showing a delay but not inhibition of 
implantation after the blastocyst transfer in COX2-deficient mice.  These results are in 
support of the theory that COX2 mediates the initial decidual response, but negates the 
importance of COX2 in further decidual growth and embryo development.  Cheng and 
Stewart (2003) suggested the importance of COX2 as an inducer of the expression of 
other mediators of decidualization and vascular permeability, such as VEGF.  
  
4.4.2. VEGF Immunolocalization in the control and hyperstimulated rat uterus 
In the present study, closure of the uterine lumen around the blastocysts and supepithelial 
stromal oedema in the control animals at 4.5 days, coincided with VEGF expression in 
the luminal and glandular epithelial cells and rounded subepithelial stromal cells at the 
antimesometrial side of the lumen.  In contrast, the subepithelial stroma of the 
hyperstimulated animals was compact and the uterine lumen highly folded and dilated. 
VEGF was immunolocalized to the luminal epithelial and glandular cells, but not 
localized to the stroma. Western blot did not show any results. 
 
Studies on the normal mouse uterus have shown VEGF localization in the luminal 
epithelial cells and stroma on day 4 of pregnancy (Chakraborty et al., 1995). VEGF was 
thus suggested to be the signal for generalized vascular permeability in the stroma prior 
to implantation (Chakraborty et al., 1995).  
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VEGF is a crucial mediator for vascular permeability during the peri-implantation in 
rodents and humans (Cullinan-Bove and Koos, 1993; Chakraborty et al., 1995; Hyder et 
al., 1996) and a promoter of angiogenesis (Ferrara, 1996; Matsumoto et al., 2002; 
Krussel et al., 2003).  In addition, it is also well established that vascular permeability 
and angiogenesis are hormonally regulated in the reproductive system of rodents and 
humans (Shweiki et al., 1993; Hyder and Stancel, 1999; Perrot-Applanat et al., 2000; Ma 
et al., 2001).  Ma et al. (2001) have shown that oestrogen induces vascular permeability 
which coincides with the expression of VEGF, while oestrogen is also responsible for 
inhibiting angiogenesis.  In addition it has been shown that VEGF receptors Flk-1/KDR 
are up-regulated by VEGF in the absence of a direct oestrogen effect (Harve et al., 2006). 
Progesterone has little effect on vascular permeability but stimulates uterine angiogenesis 
(Ma et al., 2001; Walter et al., 2005). 
  
Hyder et al. (1996) stated that the stroma with the highest blood vessel density in the 
uterus responds with massive oedema after hormone treatment.  Also, isolated stromal 
cells express increased VEGF mRNA after treatment with a physiological concentration 
of oestrogen or both oestrogen and progesterone (Perrot-Applanat et al., 2000).  Hyder 
(2002) stated that the VEGF is up-regulated at the low oestrogen concentrations in the rat 
uterus.  In the human uterus oestradiol up-regulates all VEGF isoforms (Bausero et al., 
1998).  Srivastava et al. (1998) stated that progesterone does not alter expression of 
VEGF, while Ancelin et al. (2002) have shown up-regulation of the VEGF189 isoform in 
the human uterus under the influence of progesterone. 
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In the present study, the nidatory oestradiol surge in the control animals at 4.5 days 
indeed induced stromal vascular permeability which coincided with epithelial and stromal 
VEGF immunolocalization.  However, it appears that increased oestradiol levels inhibited 
VEGF expression and vascular permeability in the stroma of the hyperstimulated 
animals.  It is more likely that the high oestradiol levels in these animals altered 
morphology of the uterus which was unsatisfactory for the blastocyst implantation, while 
suppression of VEGF in the stroma of these animals may be a result of aberrant COX2 
expression at the site of implantation.  This finding is in agreement with Cheng and 
Stewart (2003) who suggested that COX2 may be essential for VEGF expression. Thus, 
the aberrant COX2 expression on 4.5 days in the hyperstimulated animals, may have 
failed to induce VEGF stromal expression and resulted in the suppression of the 
fenestration of the thin blood vessels as reported by Kramer (1997).   
 
The other possibility for the failure of the stromal VEGF expression and decidualization 
might be that the predominant VEGF isoforms in the rodent uterus (VEGF120 and 
VEGF164) exist as secreted forms (Houck et al., 1991).  Since VEGF immunolocalization 
was most predominantly found in the apical portions of the luminal and glandular 
epithelial cells of the hyperstimulated animals at all consecutive stages of pregnancy, it is 
possible that VEGF produced in these cells was secreted into the lumen and did not act 
on the stroma to induce vascular permeability. 
   
It has also been shown that human blastocyst expresses mRNA encoding for the free 
VEGF proteins which induces vascular permeability at the implantation site (Krussel et 
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al., 2001).  It was suggested that only the free VEGF isoforms are able to induce 
angiogenesis at the implantation site and be involved in the process of embryo 
implantation (Krussel et al., 2001). VEGF was also detected in the giant trophoblast cells 
and early yolk sac (Jakeman et al., 1993). 
  
In the present study, implanting embryos of control animals at 6.5 days showed VEGF 
immunolocalization. This coincided with VEGF immunolocalization in the decidual cells 
of the subepithelial stroma.  The VEGF was also strongly expressed in the cells adjacent 
to the stroma and implanting blastocyst which appeared to be the trophoblastic cells. This 
was consistent with the study by Jakeman et al. (1993).  However, in the hyperstimulated 
animals at 6.5 days, blastocysts present in the lumen were not attached to the luminal 
epithelium.  Decidualization of the stromal cells was not evident and these cells did not 
show VEGF immunolocalization. It appears that the initiation of the stromal VEGF 
expression may require the presence of the implanting embryos. 
The observations in the present study are also in support to the previous observations that 
non-decidual stromal cells do not express VEGF (Srivastava et al., 1998).   
 
It has been previously reported that the subepithelial stroma is the most potent region for 
the micro-vessel growth in the rodent uterus (Shweiki et al., 1993). The primary decidual 
zone immediately surrounding the implanting blastocyst expressed scanty VEGF 
immunolocalization, while intense VEGF localization was evident on the mesometrial 
side and in the secondary decidual zone in the control animals on day 6.5.  The present 
study is in support to the observation by Shweiki et al., (1993), as numerous blood 
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vessels were observed in the primary decidual zone in the control animals at 6.5 days of 
pregnancy.  It appeared that the intense VEGF immunolocalization in the primary 
decidual zone at the previous stages of pregnancy, particularly at 5.5 days at the 
antimesometrial side facilitated angiogenesis and development of new blood vessels.  
Cessation of VEGF expression in the primary, but more intense expression in the 
secondary decidual zone and at the mesometrial side observed in the present study, may 
have been induced by extensive decidualization at these sites. Vascular permeability and 
angiogenesis failed to occur in the hyperstimulated animals at 6.5 days which was 
confirmed by the compact appearance of the stroma and fewer blood vessels, when 
compared to the control animals at the same stage of pregnancy. 
   
The biological response of VEGF is achieved by it binding to transmembranous tyrosine 
kinase receptors (Ferrara, 1996).  Also, VEGF binds to the heparin-sulfate proteoglycans 
on the cell surfaces or extracellular matrix, necessary to induce release of other 
angiogenic factors, such as basic fibroblast growth factor (bFGF) (Krussel et al., 2001).  
It is thought that VEGF and bFGF have synergistic effects in induction of endothelial cell 
proliferation and angiogenesis (Srivastava et al., 1998).  In the human uterus, VEGF
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splice variant is unable to bind to the extracellular matrix, due to absence of the exons 6 
or 7 which contain heparin-binding domains (Krussel et al., 2001).  Thus, failure of the 
stromal oedema and vascular permeability in the hyperstimulated rats may be explained 
by an inability of VEGF 120, one of the most predominant splice variants in the rodent 
uterus, to bind to the extracellular matrix and induce secretion of bFGF.   
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Decidualization requires an increased oxygen supply for the survival of the newly formed 
cells (Diakoku et al., 2003).  A strong correlation exists between hypoxia and VEGF 
expression in physiological angiogenesis (Bates and Harper, 2003; Daikoku et al., 2003; 
Ryzhov et al., 2007).  It is also known, that a reduction in oxygen concentration below 
2% induces VEGF mRNA in many cell types (Zhang et al., 1998).  Thus, it is possible 
that hypoxia occurred causing strong VEGF immunolocalization at the mesometrial side 
and in the secondary decidual zone in the uterus of the control animals at 6.5 days which 
may have induced vascular permeability and angiogenesis.  Chakraborty et al. (1995) 
suggested that VEGF expression at the mesometrial side in uteri of mice on day 5 of 
pregnancy contributes to angiogenesis for the establishment of the placenta. 
 
In addition to the detrimental change in the uterine morphology as a result of raised 
oestradiol concentrations, the ovarian hyperstimulation syndrome (OHSS) is a severe 
complication following treatment with gonadotrophins.  VEGF is implicated in the 
pathogenesis of OHSS due to its effect on vascular permeability (Garcia-Velasco et al., 
2004) and through the mediation of hCH on the up-regulation of VEGF (Wang et al., 
2002). The ovary is the main source of VEGF (Garcia-Velasco et al., 2004).  The fact 
that VEGF is produced by stimulation of both FSH and hCG, which are used in IVF and 
ET techniques, emphasizes the importance of balanced, or even decreased doses of these 
hormones in order to prevent the risk of OHSS.  This may allow for successful 
superovulation and a favorable uterine environment for blastocyst implantation.  
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5.0 CONCLUSION      
 
Superovulation was achieved by the administration of the exogenous hormones, FSH and 
hCG.  Administration of the exogenous hormones altered the physiological levels of 
oestrogen and progesterone at the time of preparation of the uterus for blastocyst 
implantation. The increased oestrogen levels in the hyperstimulated animals at the time of 
implantation had deleterious effects on the morphology of the uterus which resulted in 
failure of blastocyst implantation.  In addition, the exogenous hormones had a negative 
effect on the expression and distribution of VEGF and COX2 in the uterine tissue during 
the peri-implantation period. Thus it appears that numerous factors are important and 
need to be synchronized for implantation to occur. 
 
In order to further understand the complexities of assisted reproduction, it is necessary to 
investigate other molecules and factors that are involved in this process.  In addition, 
although experiments on the ovariectomized rodents provide invaluable information 
regarding the effects of assisted reproductive techniques on the the peri-implantation 
period, validation of these results should be carried out superimposed on the normal 
hormonal milieu of intact animals. The findings of these studies may thus provide safe 
and successful implantation in assisted reproductive procedures in the future. 
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Appendix 1 
The Schorr Staining 
Preparation (1 litter of stain) 
ethyl alcohol (50%) 
Biebrich scarlet (water soluble)    5.0 g 
orange G       2.5 g 
fast green FCF      0.75 g 
phosphotungstic acid      5.0 g 
phosphmolybdic acid      5.0 g 
glacial acetic acid      10 ml 
 
METHOD: 
1. Stain for 1-2 minutes in Schorr’s stain. 
2. Rinse in 70% alcohol 
3. Rinse in 90% alcohol. 
4. Rinse in 100% alcohol twice. 
5. Clear in xylene twice. 
6. Count in synthetic resin mountain. 



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Appendix 2 
Oestrous cycle diagram. 
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Appendix 3 
Phosphate buffered saline pH 7.6 
NaCl       16.0 g 
Na2HPO4.2H2O     3.5 g 
KCL       0.4 g 
KH2PO4      0.4 g 
2 litter distilled H2O 
 
Appendix 4 
10% Neutral buffered formalin 
formalin      100 ml 
sodium dihydrogen phosphate   3.5 g 
di-sodium hydrogen phosphate   6.5 g 
distilled H20       900 ml 
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Appendix 5   Raw data for the oestradiol and progesterone concentrations 
Day of 
pregnancy Progesterone ng/ml Sample 
Oestradiol 
pg/ml 
 Pregnant rats  Pregnant 
4.5 20.521 I1 19.424 
4.5 11.925 H3 12.449 
4.5 21.755 A3 15.589 
4.5 28.892 C1 18.163 
4.5 26.203 C4 40.808 
4.5 25.831 E2  
    
5.5 18.257 F4 12.122 
5.5 27.349 H4 23.802 
5.5 25.495 F3 17.978 
5.5 30.784 G2 17.549 
5.5 20.4 B2 32.887 
5.5 29.847 D3 31.879 
    
6.5 16.077 B1 20.386 
6.5 24.668 D2 19.516 
6.5 24.129 C2 45.854 
6.5 31.349 A4 51.91 
6.5 23.992 G4 24.738 
6.5 20.724 H1 32.693 
 Hyperstimulated  Hyperstimulated 
4.5 19.115 I2 26.737 
4.5 23.319 I3 20.272 
4.5 25.841 F2 30.627 
4.5 23.467 H2 19.459 
4.5 31.33 I4 41.092 
4.5 29.65 E3 32.583 
    
5.5 44.291 G1 35.637 
5.5 34.309 A2 26.164 
5.5 28.9 B4 31.413 
5.5 24.345 E1 29.492 
5.5 28.453 E4 66.595 
5.5    
    
6.5 35.444 A1 29.87 
6.5 32.128 G3 15.197 
6.5 36.88 F1 12.952 
6.5 26.774 D4 13.844 
6.5 39.1755 B3 14.904 
6.5 26.153 W3 20.51 
6.5 34.975 W4  
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Appendix 6 
Silane dipped slides 
2% Silane in acetone          
3 Aminopropyl triethoxy silane                            6 ml 
acetone       294 ml 
 
Method: 
1. Soak slides in 10% Contrad or Super 10 overnight 
2. Rinse in running water minimum 2 hours 
3. Dry in oven at 60°C 
4. Dip in acetone 
5. Dip in 2% silane in acetone for 30 minutes 
6. Wash in two changes of acetone 1-2 dips 
7. Wash briefly in distilled water 
8. Dry at 42°C in the incubator overnight. 
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Appendix 7 
Haematoxylin and eosin stain (Mayer’s Staining Technique) 
Haematoxylin:   haematoxylin 4 g 
distilled water 1000 ml 
potassium alum 50 g 
citric acid 1.5 g 
chloral hydrate 75 g 
    Eosin:                                   1% Eosin 500 ml 
     1% phloxine 250 ml 
     distilled water 750 ml 
   Method: 
1. Dewax in two changes of xylene (2 x 5 min) 
2. Pass through graded alcohols followed by rinsing the slides into running water. 
3. Stain in haematoxylin for 5 minutes. Wash in tap water to “blue”. Check staining 
under the microscope. 
4. If necessary differentiate by dipping slides 2-3 times in 1% acid alcohol. 
5. Wash in running water for 5 min, until nuclei are bright blue. 
6. Counter-stain in eosin for 30 sec to 1 minute. 
7. Wash briefly in running water. 
8. Slides are passed up through alcohol series and than into Xylene, mounted with 
Entellan and cover-slipped and left to dry.                                                        
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Appendix 8 
Citrate buffer pH 6  
Solution A: 0.1M citric acid  
10.5 g citric acid and 500 ml distilled water 
Solution B: 0.1M sodium citrate 
29.4 g sodium citrate and 1000 ml distilled water 
Method: 
Solution A       9 ml 
Solution B       41 ml 
Distilled H2O      500 ml 
 
Appendix 9 
TRIS buffered saline pH 7, 6 
TRIS base       6.06 g 
NaCl        8.77 g 
Distilled H20      1000 ml 
 
Appendix 10 
 
Homogenizing buffer stock 
 
50mM TRIS HCl pH 7.5 
 
10% glycerol 
 
5mM Mg acetate 
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0.2mM EDTA 
 
1% Triton-X-100 
 
Add 500 µl of 0.5 M DTT and 50 µl of protease inhibitor stock to 10 ml of 
homogenizing buffer just before the protein extraction.  
 
 
Appendix 11 
 
Reagent A for Lowry protein assay 
Reagents 
1) 2% sodium carbonate (Na2CO3) made up in 0.1M NaOH 
2) 1% copper sulphate (CuSO4.5H2O) 
3) 2% sodium potassium tartrate (NaKC4H4O6.4H20) 
 
Reagent A 
20 ml of (1) 
200 µl of (2) 
200 µl of (3) 
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Appendix 12 
Reagent B for Lowry protein assay 
Folin reagent diluted 1:4 in distilled water 
Method for Lowry protein assay: 
Use ELISA plate and disperse the following in order: 
1. 50 µl of sample 
2. 200 µl of reagent A (leave for 10 min on shaker) 
3. 50 µl of reagent B (leave for 30 min on shaker) 
4. Read absorbance at 690nm 
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Appendix 13      Raw data for the protein in the sample 
Day of 
pregnancy 
Volume of protein in 
the sample (µg/µl)  Sample 
 Pregnant rats  
4.5                3.396 I1 
4.5 5.666 H3 
4.5 3.504 A3 
4.5 2.613 C1 
4.5 2.330 C4 
4.5 2.850 E2 
   
5.5 5.031 F4 
5.5 7.435 H4 
5.5 3.214 F3 
5.5 3.543 G2 
5.5 2.313 B2 
5.5 3.140 D3 
   
6.5 2.829 B1 
6.5 3.278 D2 
6.5 3.101 C2 
6.5 3.653 A4 
6.5 3.354 G4 
6.5 3.411 H1 
 Hyperstimulated rats  
4.5 4.690 I2 
4.5 3.933 I3 
4.5 5.934 F2 
4.5 3.562 H2 
4.5 2.622 I4 
4.5 3.238 E3 
   
5.5 4.068 G1 
5.5 3.014 A2 
5.5 2.639 B4 
5.5 2.828 E1 
5.5 2.584 E4 
5.5   
   
6.5 2.187 A1 
6.5 4.242 G3 
6.5 5.978 F1 
6.5 3.518 D4 
6.5 2.777 B3 
6.5 6.099 W3 
   
 
 151 
Appendix 14 
10% SDS- polyacrylamide separating gel 
dH2O        5.9ml  
30% acrilamide monomer stock solution   5ml 
1.5M TRIS-HCl pH8.8       3.75ml 
10% sodium dodecyl sulphate (SDS)    150µl 
10% ammonium persulphate      150µl 
N,N,N’,N’-tetramethylethylenediamine (TEMED)  6µl 
 
Appendix 15 
Electrophoresis Tank Buffer 
0.025M TRIS pH 8.3 
0.192M glycine 
0.15 SDS 
 
Appendix 16 
Sample transferring buffer pH 6.8 
0.125M Tris-HCl pH 6.8 
4% SDS 
20% glycerol 
10% ß mercaptoethanol 
10µg/ml bromophenol blue  
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Appendix 17 
Towbin buffer 
TRIS      15.15g 
glycine     72.05g 
SDS     5g 
dH20     4000ml 
methanol     1000ml 
 
Appendix 18 
Commassie Blue Staining Solution 
0.25 g Commasie blue 
100 ml ethanol 
100 ml distilled water 
Stir for an hour until dye is completely dissolved. 
Add 25 ml acetic acid 
Add distilled water to make 250 ml of stain. 
 
Appendix 19  
Distaining Solution 1    Distaining Solution 2  
50% methanol     5% methanol 
10% acetic acid     7% acetic acid 
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